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ABSTRACT 
Diffusion tensor imaging (DTI) is a magnetic resonance imaging technique 
that in vivo visualises random translational movement of water molecules. DTI has 
inherent difficulties with low signal-to-noise ratio, sensitivity to patient motion, 
field inhomogeneities and fast T2 relaxation. It has been used in the central 
nervous system, although it has not been assessed in the peripheral nervous system. 
The aim of this thesis was to investigate if DTI in peripheral nerves was feasible, 
and if so, to investigate clinical implications. 
Study I showed that in healthy volunteers the peripheral nerves, the sciatic 
nerves, could be visualised in vivo using DTI and fiber tracking. Study II showed 
that sciatic nerves, including their division into the tibial and common fibular 
nerves, have a characteristic diffusion pattern with most impaired diffusion 
perpendicular to the nerve direction. This allowed nerves, excluding other tissues 
and artifacts, to be visualised using a novel approach called diffusion-direction-
dependent imaging and with a simple unidirectional diffusion maximum-intensity 
projection approach. Study III showed that the olfactory bulbs (OBs) and olfactory 
tracts could be visualised in vivo using DTI and fiber tracking. In Study IV, 
Parkinson’s disease (PD) patients with impaired olfaction were evaluated with DTI 
of the OBs. A novel approach of DTI was used, taking advantage of the 
technique’s inherent directional information, for region of interest placement and 
diffusion measurements in the OBs. In the PD patient group diffusion was altered 
in the OBs, compared to healthy controls. This was hypothesised, since α-synuclein 
inclusions and Lewy neurites interfering with nerve structure have been detected in 
the OBs. However, the coefficient of variation between two identical DTI series 
was high, due to the small size of the OBs and their location in an area susceptible 
to artifacts, and the difference between the groups was statistically significant only 
for the first of two series. In Study V, patients of the Swedish ‘Huddinge 
Spinocerebellar ataxia (SCA) Family’ with peripheral neuropathy, were evaluated 
with DTI of a peripheral nerve. Diffusion alterations were found in peripheral 
nerves in SCA patients, compared to healthy controls, which was statistically 
significant. 
In conclusion, DTI in peripheral nerves is feasible and can be used to detect 
diffusion alterations in OBs in PD patients and in peripheral nerves in SCA 
patients with peripheral neuropathy. 
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1. AIMS OF THE THESIS 
The aim of the thesis was to investigate if diffusion tensor imaging (DTI) in 
peripheral nerves was feasible, and if so, to investigate clinical implications. 
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2. INTRODUCTION 
 
2.1 NEUROANATOMY 
The central nervous system (CNS) constitutes of the brain and spinal cord, 
whilst the peripheral nervous system (PNS) is constituted of nerve structures 
outside the pial membrane of the brainstem and spinal cord. There are 12 pairs of 
cranial nerves exiting from the brain. The optic nerve (I) and olfactory nerve (II) 
are brain extension, thus part of the CNS, while the cranial nerves III-XII are part 
of the PNS1. There are 8 pairs of cervical, 12 pairs of thoracic, 5 pairs of lumbar, 5 
pairs of sacral and one pair of coccygeal nerves. The brain is further divided into 
the cerebrum, brainstem and cerebellum, with the brainstem divided into the 
mesencephalon, pons and medulla oblongata.  
 
 
2.1.1 Peripheral nerves 
A peripheral nerve cell, a neuron, is constituted of a cell body and a long cell 
projection called axon, both containing organells and cytoskeleton. Cell bodies of 
motor neurons are located in the ventral horns of the spinal cord and cell bodies of 
the sensory neurons in the dorsal spinal ganglions. The axon conducts the electric 
impulse2. Motor and sensory axons are surrounded by a myelin sheath, i.e. axons 
are myelinated, and the myelin is organised in concentric double phospholipid 
layers3. At small nodes along the axons there is no myelin, and the electric impulse 
‘jumps’ between these nodes, which speeds up nerve conduction. The internodal 
myelin is supplied and produced by one Schwann cell (in the CNS, myelin is 
produced by oligodendrocytes). Axons that conduct heat and pain are 
unmyelinated1,2,4,5. 
Each axon is surrounded by loose connective tissue called endoneurium. 
Several axons are bunched together in fascicles, which are surrounded by multiple 
layers of dense connective tissue called perineurium. These fascicles are themselves 
bunched together and surrounded by dense irregular connective tissue, with thick 
collagen and elastin fibers, called epineurium. Proximally the epineurium is 
continuous with the dural membrane. This connective tissue, which supports and 
protects the nerves, is produced by fibroblasts. Within the perineurium and 
epineurium there are many anastomosing capillaries. In larger nerves, variable 
amounts of interfascicular adipose tissue (loose perineurium) are present. In this 
thesis, the term nerve fiber is used for nerve fibers that are seen for the naked eye, 
thus several millimeters in diameter. The myelinated axon diameter is 
approximately 4-10 µm, the myelin itself 0.5-2 µm thick with 0.5-2 µm extraaxonal 
separation. The myelin sheaths extend, i.e. the internodal distance, approximately 
250-1000 µm1,2,4,5. The thickness of myelin is proportional to the axon diameter, 
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which in turn is proportional to the internodal distance2. The diameter of a 
myelinated nerve axon is directly proportional to its conduction velocity6. 
Unmyelinated axons are approximately 0.2-3.0 µm in diameter and more numerous 
than myelinated axons1. Approximately 5-20 unmyelinated axons are bundled 
together with cytoplasm from one Schwann cell, isolating the axons from each 
other. If a nerve biopsy is required in patients, it is often performed on the sural 
nerve. It is an almost purely sensory nerve and the myelinated axons are 
approximately 2-16 µm in diameter2. 
In pathological conditions, either the axon/cell body or myelin/Schwann cell 
is primarily affected, with the counterpart often being affected secondarily. In 
axonopathy the axon is primarily affected and in neuronopathy the cell body. In 
axonopathy there is axonal degeneration and secondarily the myelin disintegrates. A 
focal traumatic lesion leads to Wallerian degeneration of the distal portion of the 
axon. In slowly evolving axonopathies and neuronopathies only few nerve cells are 
simultaneously affected. Disease evidence can therefore be sparse on 
histopathological examination. Secondarily to axonal degeneration, muscles lose 
their neural input and become atrophic 2. 
Segmental demyelination occurs when the Schwann cell or the myelin sheath 
is primarily affected. Schwann cells are affected irregularly with an uneven 
demyelination of the axon. Remyelination can occur, although the myelin sheath 
will be thinner and the internodal distance shorter. Many chronic demyelinating 
neuropathies are followed by axonal degeneration2. 
 
 
2.1.2 Olfactory nerves and olfaction 
The olfactory bulb (OB) together with the olfactory tract is often called the 
‘olfactory nerve’, although the real olfactory nerves are the numerous bipolar 
neurons connecting through the cribriform plate. These neurons are the only ones 
connecting CNS directly with the external environment1,7. From the substantia 
perforata anterior, at the inferior surfaces of the frontal lobes, medial, intermediate 
and lateral striae exit the brain and unite to form the olfactory tract. The olfactory 
tract enlarges distally into the OB which is a brain extension. The olfactory tracts 
are localised in the olfactory sulci and distally, including OBs, in the olfactory 
grooves of the ethmoidal bone7. 
Olfactory receptors are located within the mucus of the olfactory 
epithelium, in the upper and posterior parts of the nasal cavity, just inferior to the 
cribriform plate. These chemosensitive receptors are dendritic projections from the 
olfactory cell bodies located in the mucosa1. Unmyelinated axons project from 
these cell bodies through the cribriform plate to the OB, where they in glomeruli 
synapse with mitral and tufted cells. The OB consists of 6 cellular layers8 with 
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afferent and efferent myelinated fibers running in the olfactory tract to the brain. 
Although a few axons cross the midline through the anterior commisure, olfaction 
is regarded as an uncrossed sense1,7. Located inferior within the OB and olfactory 
tract are cells of the anterior olfactory nucleus, which are affected early in 
Parkinson’s disease9. Olfaction is unique as a sense, in that it is partially directly 
connected to the cerebral cortex and partially via thalamus. Olfactory central brain 
areas are the orbitofrontal area, connecting through the thalamus, and the piriform 
and entorhinal areas connecting directly with the olfactory tracts. Olfaction does 
not have a central topographic organisation, which by contrast is seen in visual and 
sensory senses. There are approximately 1000 different olfactory receptor types and 
approximately 10000 neurons of each receptor type. Glomeruli in OB are 
connected to neurons expressing the same receptor type7,10. 
 
 
2.2 MAGNETIC RESONANCE IMAGING 
In 2003 Sir Peter Mansfield and Paul C. Lauterbur were awarded the Noble 
Prize ‘for their discoveries concerning magnetic resonance imaging’. Magnetic 
resonance imaging (MRI), also called nuclear magnetic resonance imaging, produce 
images based on properties of atomic nuclei that possess a total non-zero spin. In a 
simplified view, spin is angular momentum of particles and since atomic nuclei are 
positively charged, those with a total non-zero spin will behave as small magnets 
(Figure 1). 
 
 
 
The hydrogen nucleus constitutes of one proton and hydrogen is abundant 
in the human body (approximately 63%), mainly as part of water and fat. It is the 
most common nucleus used for MRI, while phosphor is an example of another 
nucleus used. MR-scanners use a large external magnetic field, B0, to align hydrogen 
nuclei (and other nuclei with a total non-zero spin) in the same or opposite 
direction of the magnetic field. Aligned in same direction of the magnetic field is 
the low-energy state, while in the opposite direction is the high-energy state (there 
is a dynamic equilibrium between the two states). A higher proportion of the 
protons is aligned along the magnetic field, although the difference is very small 
(Figure 2). 
 
8 
 
 
 
At 1.5 Tesla this proportion (in room temperature) is approximately 1.5 parts per 
million and at 3.0 Tesla 3 parts per million. Nuclei with a total non-zero spin will 
precess around the external magnetic field with a unique frequency, called the 
Larmor frequency, 0. At 1.5 T it is for hydrogen 63 Mhz (63 million times per 
second, for comparison it is for phosphor 26 Mhz at 1.5 T) and it is 128 Mhz at 3.0 
T. The Larmor frequency is shown in Equation [1]. 
 
                                                      [1] 
 
It depends on the external magnetic field B0 and the gyromagnetic ratio , which is 
specific for atomic nuclei. The small proportion of protons that is aligned along the 
magnetic field can be viewed as a collective magnetic vector, M, constituted of the 
sum of each proton’s magnetic vector, µ (Figure 3). 
 
 
 
Figure 3. Protons are precessing around B0 with frequency 0 at an angle θ. Each proton’s magnetic vector 
µ is summarised to a collective M vector. 
 
A radiofrequency (RF) pulse is transmitted with a coil (electromagnetic 
waves/photons). If the transmitted frequency is the same as for the 0, i.e. the 
resonance frequency, the protons get excited. The RF pulse is created with an 
alternating current, likewise an alternating magnetic field, B1. This alternating B1 can 
be viewed as two magnetic fields rotating in opposite directions (Figure 4). 
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Since one of the rotating magnetic fields is rotating in the same direction and at the 
same speed as 0, energy can be exchanged, i.e. resonance (Figure 5). 
 
 
 
Since B1 is a magnetic field, M will rotate around both B1 and B0. Since B1 and 0 
have the same frequency, this can be seen isolated as a ‘rotating frame of reference’, 
i.e. M is rotating around B1 (Figure 6). 
 
 
 
Depending on the strength and length of the RF pulse, M will ‘flip’, i.e. rotate, a 
specific angle around B1, e.g. 90 degrees. When not seen in the ‘rotating frame of 
reference’, according to Eq. [1], since B1<<B0 then 1<<0, M will form a spiral 
pattern (Figure 7). 
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When the RF pulse is turned off, the protons will return to their equilibrium, thus 
relax and emit RF waves, which are received by a coil and used to produce images. 
The time to reach equilibrium depends on exponential T1 and T2 relaxation times.  
 
 
2.2.1 T2 and T1 relaxation 
Relaxation of magnetisation in the transverse direction Mxy constitutes the 
T2 relaxation time 
 
                                           [2] 
 
and relaxation in the longitudinal direction Mz the T1 relaxation time. 
 
                                                [3] 
 
T2 relaxation is ‘spin-spin relaxation’. There are always fluctuations/motion 
in materia, even at zero Kelvin degrees (otherwise the Heisenberg uncertainty 
principle would be incorrect). As a consequence, protons will come closer or 
farther away from other protons, and the local magnetic field will thereby increase 
or decrease. According to Eq. [1] the frequency will increase or decrease and the 
protons will dephase, thus the spins will precess less coherently (Figure 8). 
 
 
 
Figure 8. M consists of numerous µ. If protons are subjected to slightly different B0 they will no longer 
precess coherently. The protons dephase and M exponentially decreases.  
 
T2 relaxation is a non-reversible process and it is shorter for lipids than for water. 
Larger molecules, such as lipids, as compared to water, comprise more protons and 
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have a larger local magnetic field. These larger molecules also have slower motion 
than smaller molecules. This will result in larger variations in the local magnetic 
field, since larger molecules can remain in contact for a longer period. In solids, T2 
relaxation is very short, since the local magnetic field variation is fixed, while liquids 
having motion of materia lessen the effect. Inhomogeneities in B0 will also 
contribute to T2 relaxation. This can be reversed in a spin echo sequence, but not 
in a gradient echo sequences. In gradient echo sequences the relaxation time is 
therefore denoted T2*. 
Longitudinal relaxation, called ‘spin-lattice relaxation’, is T1 relaxation. 
During this process energy is returned to the lattice, i.e. the tissue. This can occur 
when fluctuations in tissues are similar to the 0 and will depend on several factors. 
Two of them are molecule size and the presence of macromolecules. Very large 
molecules have slow motion impeding this process, while for small molecules, e.g. 
water, the motion is too fast. Medium-sized molecules have the best energy transfer 
and T1 relaxation is consequently shorter for fat than for water. Macromolecules, 
e.g. proteins, with available hydrophilic binding sites will also shorten T1. Water 
will form hydration layers, both at the binding sites and unbound water close to the 
molecules. This will slow down water motion and make energy transfer easier. 
 
 
2.2.2 MRI images and k-space 
Conventional MRI images are constructed of pixels with signal intensity (S) 
depending on the registered amplitude of the voxel’s magnetic vector Mxy. The 
signal intensity measures will depend on many parameters, e.g. tissue relaxation 
time, number of protons, repetition time (TR), echo time (TE), other pulse 
sequence parameters, magnetic field, coil, matrix and slice thickness. 
Since the vector Mxy is rotating, it induces an alternating sinusoidal current in 
the receiver coil. By gradient coils, a linearly changing magnetic field is used to 
spatially localise protons in one predetermined plane, since the frequency will 
correlate to the location. The registered signal constitutes of all co-registered 
frequencies and is stored in ‘k-space’ in rows (kx), i.e. frequency encoding (Figure 
9). 
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To localise protons in a second dimension the signal is sampled multiple 
times, each time changing the strength of the gradient magnetic field in this 
dimension. The registered signal is stored in further rows in k-space and 
consequently there is a pseudo frequency in the other axis (ky), i.e. phase-encoding. 
Via Fourier transformation, k-space is reconstructed to an image. There are several 
ways of collecting k-space, e.g. the above described rectilinear non-EPI (echo 
planar imaging) and others as EPI, radial and spiral. 
 
 
2.3 DIFFUSION-WEIGHTED IMAGING 
In 1986 Le Bihan et al showed that diffusion-weighted imaging (DWI) in vivo 
can be used to visualise random translational movement of water molecules, i.e. 
diffusion11. In DWI a T2-weighted spin echo sequence is used together with 
gradient pulses. Without diffusion-weighting each voxel has the signal intensity S0. 
Short strong gradient pulses, i.e. linear magnetic field variation, are used to 
accomplish diffusion-weighting. The gradient pulse induces a position dependent 
phase change of protons. A short pause follows to allow the water molecules to 
move (diffuse). After the pause an equivalent, but inverted gradient pulse is applied. 
Between the gradient pulses the refocusing 1800 RF pulse is applied, consequently 
both gradient pulses are in the same direction (Figure 10). 
 
 
 
  
13 
 
Depending on the distance the water molecules have moved from their initial 
position, they will be exposed to a different magnetic field gradient. The initial 
phase will thereby not be restored, which results in a lower signal intensity, S1. 
 
S1=S0e
-(TE/T2)e-bD                                               [4] 
 
TE=echo time, T2=T2 relaxation time, b=’diffusion-sensitising factor’, 
D=diffusion coefficient. 
 
Diffusion of water molecules is described statistically by a displacement 
probability distribution6. In biological tissue this Gaussian distribution is not 
correct, due to barriers (e.g. membranes, organelles), membrane permeability, intra- 
and extracellular space, cellularity and viscosity12,13. D is therefore called ADC 
(apparent diffusion coefficient), although the exact mechanisms correlating 
diffusion and physiological parameters are not fully known12. The ‘diffusion-
sensitising factor’, i.e. the b-value, is shown in Eq. [5]. 
 
b=γ2G2δ2(Δ-δ/3)                                              [5] 
 
The b-value depends on γ=gyromagnetic ratio, G=diffusion-encoding gradient 
strength, δ=diffusion-encoding gradient duration and Δ=diffusion-encoding 
gradient interval (Figure 10). The b-value accounts for the degree of diffusion-
weighting and is user-dependent. As a consequence of a higher b-value there is loss 
of signal, thus a lower signal-to-noise ratio (SNR). Diffusion, ADC (D), can be 
calculated using the signal intensities S1 and S0, and the b-values. 
 
                                          [6] 
 
To illustrate how the measured signal intensity depend on ADC, assume b0=0, 
which is common in DWI, and rearrange Eq. [6] into Eq. [7]. 
 
                                                 [7] 
 
From Eq. [7] it is noted, that if there are two types of tissues with the same S0 and 
the same b-value is used, tissues with a high ADC will have a lower S1 compared to 
tissues with a low ADC. However, tissues can have different S0 (a T2-weighted 
sequence is used). In a graph with the logarithmic signal intensity plotted on the 
vertical axis and the b-value on the horizontal axis, a higher ADC will be illustrated 
as a steeper curve (Figure 11). 
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In brain imaging, a b-value of 1000 s/mm2 is considered optimal14,15. T2 
relaxation time in muscles is much shorter compared to brain tissue. Since the 
diffusion-weighted sequence is based on a T2-weighted sequence, a consequence of 
the shorter T2 relaxation time is a lower SNR in the extremities14. Thus, DWI 
performed in the extremities compared to the brain, can be more difficult, since 
DWI is a technique suffering from low SNR16,17. Since DWI measures microscopic 
water molecule movement, it is also very sensitive to patient motion. The fastest 
sequence filling k-space, thus minimising patient motion during k-space collection, 
is EPI. This sequence traverses the entire k-space in one single collection. It was 
actually proposed by Sir Peter Mansfield in 1977 and was later proved to be useful 
in practice18. 
The diffusion-encoding gradient is applied in a direction, e.g. anterior-
posterior. To assess diffusion independent of the direction, it is measured in 3 
orthogonal directions and summed, which is called the trace. By dividing the trace 
by three, the average ADC is calculated, which is called the mean diffusivity (MD). 
 
 
2.4 DIFFUSION TENSOR IMAGING 
If diffusion is equivalent in all directions (e.g. in pure water) it is isotropic. 
Most of the body tissue is inhomogeneous and diffusion is therefore not uniform 
in all directions, consequently it is anisotropic. In 1994 Basser et al described DTI 
to image anisotropic diffusion19. In each voxel diffusion is measured in at least 6 
unique (non-collinear) directions plus a reference without diffusion-weighting. 
Subsequently a tensor is calculated, which represents diffusion in 3 dimensions. 
The tensor is often visualised as an ellipsoid (Figure 12). 
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The diffusion tensor ellipsoid is represented by 3 orthogonal eigenvectors (ordered 
as λ1≥λ2≥λ3), each having an eigenvalue. λ1 is the eigenvector correlating to the 
largest eigenvalue. Different properties of the tensor can be calculated, e.g. 
fractional anisotropy (FA), which displays the degree of anisotropy (total anisotropy 
FA=1 and isotropy FA=0). 
 
                                    [8] 
 
The diffusion measured in one direction, e.g. x-axis, is also dependent on the other 
directions, which is taken into account in the tensor calculation12. 
 
 
2.4.1 Nerves and DTI 
In 1990 Moseley et al showed that diffusion is anisotropic in white matter in 
the central nervous system of cat20. In two different studies in 1991, Moseley21 et al 
and Hajnal22 et al, showed that diffusion in (human) peripheral nerves also is 
anisotropic. Nerve diffusion is anisotropic due to their tubular structure, with the 
highest diffusion (λ1) parallel with the nerve, while it is restricted perpendicular to 
the nerve6,21. Although there is no exact explanation for diffusion anisotropy seen 
in nerves, it is considered to be due to hindrance of water molecules perpendicular 
to the membranes in the densely packed axons. Myelin sheaths could modulate 
anisotropy, although it is has been hard to assess to what degree, while axonal 
transport and microtubules does not contribute to anisotropy23-25. Diffusion within 
the axon is similar in a parallel and perpendicular direction, i.e. isotropic, whereas 
when several axons are included it is anisotropic25. Diffusion anisotropy measures, 
e.g. FA, depend on several factors, e.g. axon diameters, axon number, axon 
orientation and degree of myelination26,27. There is a weak correlation (R2=0.24) 
between FA and mean axon diameters26. R2>0.2-0.4 is considered a fair 
correlation28. According to Eq. [8] a decrease in nerve FA is due to increased 
perpendicular diffusion, decreased parallel diffusion or both. 
The voxel size used in clinical MRI studies is in a millimeter scale. The 
myelinated axon diameter is approximately 4-10 µm, the myelin 0.5-2 µm thick with 
0.5-2 µm extraaxonal separation4. If a maximum axon diameter, myelin thickness 
and extraaxonal separation is assumed, the ‘total diameter’ for each axon is 
approximately 14 µm and if the minimum is assumed, it is approximately 5 µm. 
Using a simple approximation, a 1.0 mm3 voxel (since the nerves are running 
parallel, the area for nerve fibers is 1 mm2) will contain approximately 5100-40000 
parallel axons, including other tissues, e.g. collagen and fat.  
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2.4.2 Fractional anisotropy colour encoded images and fiber tracking 
Tensor information can be visualised in different ways, e.g. fractional 
anisotropy colour encoded image maps (FA-CEI) with colours corresponding to 
the direction of the first eigenvector (λ1). Green corresponds to anterior-posterior 
diffusion (y-axis); red to left-right (x-axis) and blue to superior-inferior (z-axis). 
Another approach is fiber tracking/tractography, first shown in 1999 by Mori29 et 
al. It generates 3-dimensional fibers by joining tensor information in adjacent 
voxels, according to user-defined parameters. It is based on the λ1-direction which 
correlates to the nerve direction. An array of different software programs for fiber 
tracking exists, both vendor-supplied and freely available on the internet30. 
 
 
2.4.3 Compartments 
Body tissue can be divided into intra- and extracellular volumes, i.e. two 
different compartments. In the body approximately 80% is intracellular volume and 
20% is extracellular volume. Intracellular volume is more viscous, since it contains 
more proteins. However, the diffusion signal cannot be explained by these two 
compartments12. 
The diffusion signal in vivo does not have a mono-exponential decay. 
However, it is unclear if it fits best with a bi-exponential decay, a tri-exponential 
decay or with other models12,31,32. The two compartments, intra- and extracellular 
volume, cannot explain the bi-exponential decay12. A two water pools model has 
been proposed as an explanation for bi-exponential decay, with a slow (ADC 
0.3×10-3 mm2/s) and fast (ADC 1.3×10-3 mm2/s) component, in slow or 
intermediate exchange31. 
 
 
2.5 MAGNETIC FIELD 
Improving SNR is of great importance, since DWI and DTI inherently are 
suffering from low SNR, which will affect both precision and accuracy16,33. 
Diffusion itself is independent of the external magnetic field strength, albeit an 
indirect effect can be seen, due to the altered T1 and T2 relaxation times14. SNR 
theoretically doubles from 1.5 T to 3.0 T, since it varies linearly with the external 
magnetic field. However, tissue T1 relaxation time increases with a higher magnetic 
field and TR consequently has to be prolonged, otherwise SNR gain is impaired. At 
3.0 T compared to 1.5 T, the T2 relaxation decreases, although to a lesser extent, 
necessitating only a slightly shorter TE. At 3.0 T compared to 1.5 T, the T1 
relaxation time in muscles increases approximately 20% and the T2 relaxation time 
decreases approximately 10%34. In diffusion measurements in calf muscles, 
doubling from 1.5 T to 3.0 T, whilst using nearly identical MRI protocols, results in 
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a SNR increase by a factor of 1.6414. The specific absorption rate, i.e. energy 
deposition, increases with the square related to the magnetic field, thus will it 
quadruple from 1.5 T to 3.0 T35. 
 
 
2.6 MAGNETISATION TRANSFER IMAGING 
Magnetisation transfer imaging utilises that body water is within two 
magnetisation pools, a mobile and a non-mobile water pool, which are in 
magnetisation equilibrium. Non-mobile water, which is not imaged in conventional 
MRI sequences, is bound to macromolecules, e.g. myelin. By applying an off-
resonance RF pulse, saturating the non-mobile pool, the mobile water will 
exchange magnetisation and the measured signal will decrease. When comparing 
the signal measured in an identical sequence, with and without an off-resonance 
pulse, magnetisation transfer ratio (MTR) can be calculated36,37. Reduced MTR 
compared to normative values, indicates a reduction in free water magnetisation 
exchange. This is non-specific, but in white matter in multiple sclerosis it is related 
to axon damage and myelin content, i.e. demyelination36,38. However, MTR is also 
correlated to inflammation and oedema39. MTR has been evaluated in vivo in human 
normal nerves40,41, although so far no studies are published on peripheral nerve 
pathology. 
 
 
2.7 PARKINSON’S DISEASE 
Parkinson’s disease (PD) is a progressive neurodegenerative movement 
disorder42,43. It primarily affects the elderly and the incidence thereafter quickly rises 
with age. Approximately 10% of patients are below 45 years of age43. It is a clinical 
diagnosis characterised by motor symptoms, i.e. tremor (4-6 cycles/second), rigidity 
and bradykinesia, often being asymmetric42-44. Patients with newly diagnosed PD 
should response to levodopa treatment44. There is accumulating evidence that 
certain non-motor symptoms, such as hyposmia, rapid eye movement (REM) sleep 
behaviour disorder, constipation and depression precede the motor symptoms by 
several years45. The patient and family members have often retrospectively noticed, 
after the PD diagnosis, symptoms and signs going back for more than a decade43. 
Even dementia and dysautonomia are frequent in the disease, especially in late 
stages42. 
PD is a synucleinopathy, which characteristically involves pars compacta of 
substantia nigra (SN), although histopathological data suggests that PD initially 
affects the olfactory bulb (OB) and the dorsal motor nucleus of the vagal nerve9. 
The cause of the disease is still unclear and few environmental factors have been 
found. It is likely that PD already existed in the preindustrial era. Susceptibility 
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genes have been found and caffeine, an adenosine A2 receptor antagonist, seems to 
have a protective effect43. 
In parkinsonism, i.e. symptoms seen in PD, structural MRI can reveal other 
diagnoses, e.g. tumours in the basal ganglia or thalamus, normal pressure 
hydrocephalus, Creutzfeldt–Jakobs disease or manganism46. Vascular parkinsonism 
show on MRI extensive subcortical white-matter ischaemic changes43. Other 
differential diagnoses in parkinsonism are the much more unusual movement 
disorders progressive supranuclear palsy, multiple system atrophy and corticobasal 
degeneration. Single-photon emission computed tomography (SPECT) using 123I-
Ioflupane (DaTSCAN) can be used in PD diagnostics. 123I-Ioflupane has affinity to 
the dopamine transporter, a presynaptic protein regulating dopamine concentration 
in the synaptic cleft47. In PD there is a reduction of uptake in the putamen, a 
specific brain region48. However, DaTSCAN cannot effectively differentiate 
between PD, progressive supranuclear palsy, multiple system atrophy and 
corticobasal degeneration47. DaTSCAN can strengthen the PD diagnosis, since only 
4-14% of patients with early onset of disease have normal scans43. On conventional 
MRI, multiple system atrophy can show non-specific hypo/hyperintensities in the 
putamen and have atrophy of the pons and cerebellum. Indicative for multiple 
system atrophy is the ‘hot cross bun’ sign, which is a cruciform hyperintensity seen 
in the pons in T2-weighted images43,46. This is caused by atrophy and gliosis of 
transverse travelling pontocerebellar fibers46. Progressive supranuclear palsy can on 
conventional MRI show mesencephalon atrophy, recognised by the ‘hummingbird’ 
sign, and atrophy of the superior cerebellar peduncles. Olfaction impairment is 
generally not present in multiple system atrophy, progressive supranuclear palsy or 
vascular parkinsonism43. 
On histopathological examination α-synuclein-immunoreactive inclusions 
are seen in involved neurons in PD. In the brain, PD affects specific regions and 
specific neurons, but also the PNS, including the enteric nervous system. Within 
cell bodies α-synuclein inclusions present as Lewy bodies and within cellular 
processes (axons and dendrites) as spindle-like Lewy neuritis. Neurons with long, 
thin unmyelinated axons or poorly myelinated axons are especially affected, e.g. the 
olfactory and nigrostriatal projecting neurons. To transmit impulses, unmyelinated 
and poorly myelinated axons require more energy than myelinated axons, which 
could make them more vulnerable to oxidative stress. Another factor making these 
neurons more vulnerable is the lesser interaction with oligodendrocytes, which 
produce and maintain myelin, making them more sensitive to pathological 
sprouting. Lewy inclusions are regarded as a continuous pathological process and 
six neuropathological stages have been defined, with stage 1-2 being preclinical. 
Lewy inclusions are not regarded as part of natural ageing and are not seen in all 
elderly. Dopaminergic nigrostriatal degeneration is a hallmark of PD, but other 
transmitter systems are affected as well. The various stages of PD affect different 
brain regions, starting in the lower brainstem and ending in the cerebral cortex, 
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although affected areas also continuously deteriorate. In stage 1 disease, the 
anterior olfactory nucleus in the OB and olfactory tract, and the dorsal motor 
nucleus of the vagus nerve are affected. In stage 3, pars compacta of the SN is 
involved, which will ultimately lead to the loss of neuromelanin containing neurons 
and consequently the loss of pigmentation upon histopathological examination. 
When the PD patient starts to develop discrete clinical symptoms, early 
synucleinopathy changes exist in the SN, and extensive changes in the dorsal motor 
nucleus of the vagus nerve, lower raphe nuclei and locus coeruleus9. 
 
 
2.7.1 Hyposmia 
There are many entities causing hyposmia and anosmia, e.g. congenital, post-
infectious, post-traumatic, chronic rhinosinusitis, idiopathic, tumours or 
neurodegenerative disorders7,49. Despite the prior assumption of post-natal 
neurogenesis in human OBs7, which is seen in rodents and adult monkeys, a recent 
study showed none or very limited50. 
An easy method to test smell, without using complex equipment for 
threshold testing, is odor detection with the University of Pennsylvania Smell 
Identification Test (UPSIT). The correlation of UPSIT and threshold detection is 
high51. UPSIT has high test-retest reliability. The 40-item UPSIT consists of four 
booklets, each containing 10 stimuli of ‘scratch and sniff’ odorants. For each 
stimulus the participant is prompted to choose one of four options. The result is 
compared with normative data (age and gender), and the participants are scored as 
normosmic, mild microsmic, moderate microsmic, severe microsmic, anosmic or 
probable malingering (http://sensonics.com/sit-administration-manual.html). Healthy 
women as a group, perform better than men on UPSIT, which also is evident in 
other studies51. 
In some clinical entities, e.g. post-traumatic and congenital disorders, 
decreased OB volume correlates with olfactory sensitivity. However, accurate 
measurements of the thin OBs are difficult and the variation among healthy 
individuals is large52. No OB volume difference has been observed in PD patients 
compared to healthy controls53. 
 
 
2.8 SPINOCEREBELLAR ATAXIA 
Spinocerebellar ataxia (SCA) is a heterogeneous group of autosomal 
dominant neurodegenerative disorders54,55. So far, 36 SCA types have been 
described, each type caused by mutations in a specific gene or associated with a 
specific chromosome region (http://neuromuscular.wustl.edu/ataxia/domatax.html). 
Progressive ataxia, i.e. loss of coordination, is the most common first symptom, 
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with onset usually at 30-50 years of age. Additional non-ataxia symptoms are 
common and depend on the type55. The SCA prevalence in Europe is 
approximately 1-3/100 000. SCA1, 2, 3, 6 and 7 are the most common, while the 
other types are considered rare. Globally SCA3, also known as Machado-Joseph 
disease (MJD), is the most common type54,56. Varying degrees of cerebellar 
degeneration are seen in all types54. Involvement of other structures such as basal 
ganglia, brainstem, spinal cord, retinae and peripheral nerves differ between the 
types54,56. Brainstem degeneration appears to be most important in SCA1, both 
brainstem and cerebellum become atrophic in SCA3/MJD, while only the 
cerebellum is involved in SCA654,57,58. The PNS is involved in approximately 50% 
of SCA1, 80% of SCA2 and commonly seen in SCA3/MJD54,58. Atrophy of the 
spinal cord has only been described in SCA3/MJD59. 
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3. MATERIAL AND METHODS 
 
3.1 HEALTHY INDIVIDUALS AND PATIENTS 
In Study I the proximal part of the left sciatic nerve was examined in three 
healthy individuals. In Study II the distal part of the left sciatic nerve was 
examined in three healthy individuals. In Study III the ‘olfactory nerves’ were 
examined in five healthy individuals and one patient with congenital anosmia. In 
Study IV the OB, SN and corpus callosum (CC) were examined in 16 healthy 
individuals and 18 PD patients. To strengthen the validity of the PD diagnosis all 
PD patients underwent DaTSCAN quantified with BRASS software48. Asymmetry 
index was calculated for putaminal uptake, i.e. comparison of the left and right side. 
Asymmetry index=(higher SPECT signal – lower SPECT signal)/(higher SPECT 
signal)×100. Symptoms of the PD patients were scored according to Hoehn & 
Yahr and Unified Parkinson Disease Rating Scale. Unpaired two-tailed Student’s t 
test was used for statistical analyses (GraphPAD Prism 4.0; USA). A p<0.05 was 
considered significant. In Study V the brain, spinal cord and left distal sciatic nerve 
were examined in four patients of the Swedish ‘Huddinge SCA Family’ and in four 
age- and gender-matched healthy controls. All patients underwent 
electroneurography (ENeG) and patient#1 underwent a sural nerve biopsy. All 
patients were scored according to the Scale for the assessment and rating of ataxia 
(SARA)60. Pearson coefficient was calculated for correlation of SARA scores with 
MRI measurements. A p<0.05 was considered significant. Age and gender data is 
presented in Table 1. 
 
Patient/Control Age (years) Gender SARA 
#1 70/71 male/male 11.5 
#2 60/63 female/female 17.5 
#3 75/77 male/male 20 
#4 32/33 male/male 1.5 
 
Table 1. Age and gender for patients and healthy controls in Study V. 
SARA scores for patients. 
 
 
3.2 MR-SCANNERS 
In Study I, II, III and IV a 1.5 Tesla MR-scanner (Gyroscan Intera; Philips 
Medical Systems, Best, The Netherlands) was used. In Study V a 3.0 Tesla MR-
scanner (Magnetom VERIO, Siemens Healthcare) was used for the spinal cord and 
left distal sciatic nerve and a different 3.0 Tesla MR-scanner (Discovery MR750, 
General Electric) was used for the brain. 
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3.3 COILS 
In Study I and II a 2-channel phased-array coil was used. In Study III and 
IV a multi-channel phased-array head coil was used. In Study V a transmit/receive 
15-channel knee coil, a 32-channel spine coil and a 32-channel head coil were used. 
 
 
3.4 DIFFUSION-WEIGHTED SEQUENCES 
Study I 
A diffusion-weighted sequence was performed in an axial plane with a single-
shot diffusion-weighted EPI sequence, b-value 400 s/mm2 in 32 vendor-supplied 
diffusion encoded directions plus a reference image without diffusion-weighting 
[TE=70 ms, TR=4 s, slice thickness/gap=6/0 mm, 25 slices, field of view 
(FOV)=24×24 cm, matrix=96×96, voxel size=2.5×2.5×6.0 mm]. 
 
Study II 
A diffusion-weighted sequence was performed in an axial plane with a single-
shot diffusion-weighted EPI sequence, b-value 1000 s/mm2 in 36 in-house 
diffusion encoded directions plus a reference image without diffusion-weighting 
[TE=87 ms, TR=6698 ms, slice thickness/gap=4/0 mm, 30 slices, FOV=22×22 
cm, matrix=96×128, voxel sixe=2.3×1.7×4.0 mm, number of signal averages 
(NSA)=6]. Sensitivity encoding (SENSE) with an acceleration factor of 2 was used. 
Spectral presaturation with inversion recovery (SPIR) was used for fat suppression. 
The first of the 36 diffusion-encoded gradient directions was solely in the z-
direction, i.e. proximal-distal direction. The following gradient directions were 
repeated with a 50 inclination, resembling a fan, in the phase-encoding direction, i.e. 
in an anterior-posterior plane, until the complete plane was covered (Figure 13). 
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Study III 
A diffusion-weighted sequence was performed in an axial plane with a single-
shot diffusion-weighted EPI sequence, b-value 900 s/mm2 in 32 vendor-supplied 
diffusion encoded directions plus a reference image without diffusion-weighting 
[TE=83 ms, TR=6698 ms, slice thickness/gap=3/0 mm, 26 slices, FOV=23×23 
cm, acquisition matrix=128×128, reconstruction matrix=256×256, voxel 
sixe=0.9×0.9×3.0 mm, NSA=4, partial Fourier encoding=0.6]. A SENSE-factor of 
2.1 and SPIR was used for fat suppression. The diffusion sequence time was 13.31 
minutes. Post-processing with eddy current/motion correction and b-matrix 
reorientation was performed using software tools from the FMRIB software library 
(http://www.fmrib.ox.ac.uk/fsl) provided by FSL. 
 
Study IV 
A diffusion-weighted sequence was performed in an axial plane with a single-
shot diffusion-weighted EPI sequence, b-value of 900 s/mm2 in 32 vendor-
supplied diffusion encoded directions plus a reference image without diffusion-
weighting [TE=83 ms, TR=6698 ms, slice thickness/gap=3/0 mm, 26 slices, 
FOV=23×23 cm, acquisition matrix=128×128, reconstruction matrix=256×256, 
voxel sixe=0.9×0.9×3.0 mm, NSA=4, partial Fourier encoding=0.6]. A SENSE-
factor of 2.1 and SPIR was used for fat suppression. The diffusion sequence time 
was 13.31 minutes. By using software tools from the FMRIB software library 
(http://www.fmrib.ox.ac.uk/fsl), diffusion-weighted images were visually analysed 
for head movements in three reconstructed planes. Diffusion-weighted images 
were then post-processed with eddy current/motion correction and b-matrix 
reorientation. For each voxel, tensor components were calculated, i.e. eigenvectors, 
eigenvalues, FA and MD, and FA-CEI were reconstructed. The intra-individual 
variability was tested by performing two identical diffusion-weighted sequences and 
calculating the coefficient of variation CV=std(xi)/mean(xi). 
 
Study V 
A diffusion-weighted sequence was performed in an axial plane with a single-
shot diffusion-weighted EPI sequence, b-value of 1000 s/mm2 in 30 vendor-
supplied diffusion encoding directions plus a reference image without diffusion-
weighting [TE=85 ms, TR=3000 ms, slice thickness/gap=5/5 mm, slices=10, 
FOV=15.5×15.5 cm, acquisition matrix=124×124, voxel size=1.2×1.2×5.0 mm, 
NEX=6, partial Fourier encoding=5/8.] Generalised autocalibrating partially 
parallel acquisition with an acceleration factor of 3 was used. Spectral adiabatic 
inversion recovery (SPAIR) for fat suppression was used. FA-CEI were calculated 
on a voxel-by-voxel basis. Using T2-weighted images for anatomical reference, a 
circular regions of interest (ROI) approximately 6 mm in diameter, was placed in 
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the sciatic nerve on FA-CEI. The highest FA value was recorded in each slice and a 
mean value was calculated for each patient. 
 
 
3.4.1 Fiber tracking 
Study I 
Fiber tracking was performed with an IDL-based (Research Systems INC., 
Boulder, CO, USA) fiber tracking program (PRIDE) provided by Philips. Fiber 
tracking constraints were made with ROIs placed surrounding the expected 
anatomical place for the sciatic nerve in two axial slices. The largest fiber deviation 
in one step was 9.4°, minimum fiber length was 80 mm, with a step size of 0.5 
voxel. FA threshold was set to 0.3. 
 
Study III 
Software tools provided by Bioimage Suite were used for fiber tracking61. 
Fiber tracks were calculated using a fourth order method Runge-Kutta algorithm. 
Fiber tracking was initiated with a ROI placed in the expected anatomical place for 
each of the olfactory tracts. Largest fiber deviation in one step was 10°, minimum 
fiber length was 5 mm, with a step size of 0.25 voxel. FA threshold was set to 0.18. 
 
 
3.4.2 Diffusion-direction-dependent imaging 
Study II 
Two methods for nerve visualisation were tested: 
1. A method using diffusion-weighted raw image data from a single diffusion 
direction was used. With diffusion direction perpendicular to the nerve direction 
the signal is preserved, while a diffusion direction along the nerve attenuates the 
signal. Due to the course of the nerve, direction 18 (Figure 13) was perpendicular 
and therefore used. Maximum-intensity projection (MIP) images were used to 
present data, without and with a ROI surrounding the nerves to exclude other 
tissues. 
2. A method called diffusion-direction-dependent imaging (DDI), combining 
diffusion-weighted raw image data from all 36 diffusion directions via a simple 
post-processing model. For each acquired voxel, signal intensity was plotted on the 
y-axis and the diffusion directions on the x-axis. The signal intensities in a voxel 
varied with the diffusion direction and were tissue-dependent (Figure 14). 
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Figure 14. Graphs illustrating signal intensities varying over the spatial angle in voxels of different tissues. 
(A) Sciatic nerve. (B) Vessel. (C) Chemical shift artifact. (D) Muscle. 
 
An expected curve shape ( ) of a nerve was calculated by selecting 10 voxels 
from each three subject’s sciatic nerve, yielding a total of 30 curves. The 10 voxels 
from each subject were manually depicted by selecting one voxel in every third axial 
diffusion image. All voxels were selected from direction 18 (Figure 13). In distal 
slices, voxels of either the common peroneal nerve or the tibial nerve were used. 
All curves were normalised to one, and the mean expected curve was calculated and 
smoothed using a three-point Gaussian sliding window (Figure 15). 
 
 
 
Figure 15. The mean expected curve shape for a nerve calculated in three healthy subjects. The normalised 
diffusion signal and the standard deviation for each angle are shown. The peak of the curve is slightly 
shifted to negative angles due to there being most perpendicular to the nerve fiber directions. 
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In order to visualise the nerve and to suppress all other tissues, a comparison 
between the expected curve shape ( ) and the measured curve shape was made 
voxel per voxel, as shown in Eq. [9] and [10]. 
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n is the diffusion direction index and N is the number of diffusion directions. xρ(n) 
is the MR signal in voxel ρ along direction n.   is the expected curve shape from a 
nerve fiber, scaled to xρ with least squares estimation. δ is the offset in the diffusion 
direction index compensating for the direction of the nerve, and ερ is the error sum 
between   and xρ. yρ is the minimum error sum of ερ in voxel ρ. yρ was calculated 
for every voxel in the imaged volume and was used as contrast in post-processed 
images, i.e. DDI images. 
 
 
3.4.3 Inherent diffusion directional information 
Study IV 
Two methods were used for localisation and analysis: 
1. A method for OB. OBs were localised in T2-weighted images (Figure 16A, 
B) and correlated to proton density-weighted images and FA-CEI (Figure 16C). 
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Figure 16. A) Coronal T2-weighted MRI image with lines corresponding to an axial DTI slice covering 
OBs. B) Sagittal T2-weighted MRI image of an OB. C) Axial FA colour encoded images with OBs (box) 
and both medial rectus muscles visualised in green colour. Magnification images of the OBs with λy for 
each voxel. In grey colour ROIs (left and right) with highest ROI mean λy value. D) Tensor with 
eigenvectors. E) Eigenvector λ1 with its λy and λx components and αy angle. SUP: Superior; INF: Inferior; 
ANT: Anterior; POST: Posterior. Scale bar=1 mm in A, B. 
 
OB location correlated to green in FA-CEI (Figure 16C). λ1 is normalised to 1 and 
consists of three specific values in 3D space; y-axis (λy), x-axis (λx)  and z-axis (λz) 
(Figure 16D, E). If λ1 equals 1 in the y-axis (λy) the tensor is directed solely in the y-
axis. If λy <1 then λ1 is deviating with an angle αy from the y-axis (Figure 16E). 
Since λ1 is normalised to 1, the angle αy=arccos λy/λ1=arccos λy. Absolute values of 
λy of the λ1 were plotted in FA-CEI at the location of both OBs (Figure 16C; values 
retrieved by tensor calculations can be negative or positive, but the diffusion 
direction cannot be judged being anterior or posterior). A high value λy, which 
corresponds to a small deviating αy angle, indicates diffusion directed in the y-axis 
which correlates to the OB direction. A rectangular ROI (2×10 voxels; 1.8×9 mm) 
was placed in each OB at the location where the mean value of the ROI had the 
highest λy value (Figure 16C, E). The ROI for each OB was used to calculate mean 
FA, mean MD, mean λy and mean αy angle. In each individual, the OB (left or right) 
with the highest ROI λy mean value (corresponding to the smallest αy angle) was 
selected for analysis, since this has the highest association to the anterior-posterior 
direction of the OB and is least influenced by partial volume effects. The largest 
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transaxial diameters of OB were measured on coronal T2-weighted images and 
length on sagittal images (Figure 16A, B). Due to the shape of the OB an ellipsoid 
volume calculation (4/3*π*((x/2)*(y/2)*(z/2))) was used. 
2. A method for SN. SN is located close to the cerebral peduncle just below 
the level of the inferior part of the red nucleus62. A proton density-weighted 
sequence was used to find the correct level of SN in mesencephalon. By using the 
b-zero image and FA-CEI, bilateral ROIs were placed at the SN and its junction to 
the cerebral peduncle, corresponding to the blue-green interface on FA-CEI. Each 
ROI consisted of three 5×2 voxels subROIs (Figure 17). 
 
 
 
The cerebral peduncles have their nerve fibers and diffusion directed in the z-axis. 
The mean λz was therefore calculated for each subROI. A high value for mean λz 
indicates nerve fibers travelling in a superior-inferior direction, i.e. the cerebral 
peduncle. A cut-off mean value λz over 0.6 was empirically used to assume that the 
subROI was located at the interface of the cerebral peduncle and SN, with even 
higher value λz in the cerebral peduncle. The next inner subROI, on each side, was 
used for SN analysis and to calculate mean FA, mean MD and mean λy. 
For comparison, the trunk of the CC63 with its nerve fibers and diffusion 
direction in the x-axis was used. It was localised in FA-CEI and a quadratic ROI 
(10×10 voxels; 9×9 mm) was placed in both series in the same place in region II-
III, according to Hofer and Frahm64. For each ROI mean FA, mean MD and mean 
λx was calculated. 
 
 
3.5 MAGNETISATION TRANSFER SEQUENCE 
Study V 
Magnetisation transfer imaging was performed, without and with an off-
resonance RF pulse (1.5 kHz off-resonance, 10 ms long Gaussian pulse, 5000 
effective flip angle) [TE=7 ms, TR=33 ms, flip angle=10, slice 
thickness/gap=5.0/1.0 mm, slices=20, FOV=15.4×15.4 cm, acquisition 
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matrix=192×192, voxel size=0.8×0.8×5.0 mm, NSA=5]. Mean MTR was 
calculated for each patient. MTR=100×(magnetisation transfer imaging without – 
magnetisation transfer imaging with)/magnetisation transfer imaging without. On 
magnetisation transfer images, without and with the RF pulse, a ROI approximately 
6 mm in diameter was placed in identical positions as in FA-CEI, in the sciatic 
nerve. Due to proximal and distal fold-over artifacts in the magnetisation transfer 
images, the central 13 slices were used for analysis. A circular ROI, approximately 
10 mm in diameter was placed in the vastus medius muscle and mean MTR was 
calculated for each patient. 
 
 
3.6 T1-, T2- AND PROTON DENSITY-WEIGHTED SEQUENCES 
Study I 
T2-weighted imaging in the axial plane was performed for anatomical 
reference. 
 
Study II 
T1-weighted imaging in the axial plane was performed for anatomical 
reference. 
 
Study III and IV 
T2-weighted driven-equilibrium imaging in the coronal and sagittal plane of 
the OB and olfactory tracts were performed for anatomical reference. Proton 
density-weighted imaging in the axial plane of the brain (from below of 
mesencephalon to above CC), with equal slice thickness and spatial resolution as 
the diffusion-weighted sequence, was performed for anatomical reference. 
 
Study V 
The brain was examined with a T1-weighted 3D fast spoiled gradient echo 
(FSPGR) BRAVO [TR=8.1 ms, TE=3.2 ms, FOV=256 mm, acquisition 
matrix=256×256, slices=176, slice thickness=1.0 mm, voxel size=1.0×1.0×1.0 
mm, flip angle=12, prep time=450 ms, NEX=1], T2-weighted axial PROPELLER 
sequence [TR=3000 ms, TE=110 ms, FOV=240 mm, matrix=384×384, slice 
thickness=4.0 mm, voxel size=0.6×0.6×4.0 mm, NEX=1.5] and sagittal 3D CUBE 
FLAIR sequence [TR=6000 ms, TE=128 ms, FOV=240 mm, acquisition 
matrix=256×224, slices=292, slice thickness=1.2 mm, voxel size=0.9×1.1×1.2 
mm, inversion time=1860 ms, NEX=1]. 
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The spinal cord was examined with a sagittal T2-weighted sequence 
[TR=3000 ms, TE=102 ms, FOV=350 mm, acquisition matrix=512×384, 
slices=15, slice thickness/gap=3.0/0.3 mm, voxel size=1.0×0.8×3.0 mm, 
NEX=2]. 
The left distal thigh was examined with a 3D T2-weighted sequence 
[TR=1500 ms, TE=134 ms, FOV=178 mm, acquisition matrix=192×188, 
slices=96, slice thickness=1.0mm, voxel size=0.9×0.9×1.0 mm, NEX=2]. 
 
 
3.7 OLFACTION TESTING 
Olfaction was tested with the 40-item UPSIT. 
 
 
3.8 MRI VOLUMETRY AND SPINAL CORD MEASUREMENTS 
Study V 
The T1-weighted 3D FSPGR BRAVO sequence was used for MRI 
volumetry. Using software tools from the FMRIB software library 
(http://www.fmrib.ox.ac.uk/fsl), the brain was extracted from surrounding bone 
and segmented into brain tissue and cerebrospinal fluid. The brain was manually 
segmented into cerebrum, mesencephalon, pons, medulla oblongata and 
cerebellum65. The percentage of each structure, as part of the total brain volume 
was calculated. The midsagittal distance of the spinal cord was measured, at the 
midlevel of each vertebra from C1 to Th12, and mean value was calculated for each 
patient. 
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4. RESULTS 
 
4.1 PERIPHERAL NERVE DIFFUSION TENSOR IMAGING 
In Study I fiber tracking (Figure 18) of the diffusion tensor images detected 
a bundle of fibers in all 3 individuals. The location of the fibers correlated to the 
sciatic nerve. 
 
 
 
 
4.2 DIFFUSION-DIRECTION-DEPENDENT PERIPHERAL 
 NERVE IMAGING 
In all three subjects in Study II, the sciatic nerve and its division were 
visualised on unidirectional diffusion MIP images in a direction perpendicular 
(direction 18) to the sciatic nerve (Figure 19A). Chemical shift artifacts and artifacts 
from vessels partly obscured the nerves. By manually drawing a ROI over the 
course of the nerves, these artifacts could be excluded (Figure 19B). DDI images 
clearly visualised the sciatic nerve and its division (Figure 19C). 
 
 
 
Figure 19. Coronal views in one of the participants. Unidirectional diffusion MIP image (direction 18) 
without (A), and with ROI (B) surrounding the course of the nerves. C) DDI image. L: Left; F: Feet. 
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4.3 DIFFUSION TENSOR FIBER TRACTOGRAPHY OF THE 
 OLFACTORY TRACT 
In Study III, OB and olfactory tracts were visualised in all five healthy 
individuals on T2-weighted images with corresponding fiber tracking (Figure 20). 
Mean of the maximum tracking length for the right side was 9 mm (5–11 mm) and 
for the left side 11 mm (7–14 mm). For the right side the mean FA range, derived 
from fiber tracking results, was 0.19–0.23 and for the left side it was 0.21–0.28. By 
contrast, in the anosmic patient neither OB nor olfactory tracts were visualised, 
neither on T2-weighted images nor on fiber tracking images. 
 
 
 
 
4.4 MRI DIFFUSION IN PARKINSON’S DISEASE: USING THE 
 TECHNIQUE’S INHERENT DIRECTIONAL INFORMATION 
 TO STUDY THE OLFACTORY BULB AND SUBSTANTIA 
 NIGRA 
In Study IV, due to head movements during both DTI series, 1 healthy 
individual and 4 PD patients were excluded. Thus, 15 healthy individuals (44-72 
years, mean age 60, 9 men and 6 women) and 14 PD patients (47-73 years, mean 
age 64, 8 men and 6 women) were included. All 14 PD patients had a significant 
reduction of 123I-Ioflupane putaminal binding (quantified with BRASS software) 
and the mean asymmetry index was 12%. The 15 healthy individuals were 
normosmic or microsmic; 8 normosmic, 6 mild microsmic and 1 moderate 
microsmic. The 14 PD patients were anosmic or hyposmic; 7 were anosmic, 4 
severe microsmic and 3 moderate microsmic. Hoehn & Yahr scores ranged 
between 1.5 and 2.0, and total Unified Parkinson Disease Rating Scale scores 
between 24 and 43. There was a significant difference (p<0.001), with minimal 
overlap, in the UPSIT scores between healthy individuals and PD patients. 
In the first DTI series 13 healthy individuals and 13 PD patients (7 men and 
6 women in each group; healthy individuals mean age 60 and PD mean age 64; 
p=0.24) were included, and in the second 11 healthy individuals (7 men and 4 
women) and 8 PD patients (5 men and 3 women) were included (healthy 
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individuals mean age 61 and PD mean age 67; p=0.11). Of the excluded single DTI 
series, 1 was due to technical problems and 12 due to head movements. 
In all included 29 individuals the mean OB transaxial diameter was 3.0 
(minimum=2.0 mm) and mean length 11.1 mm (minimum=9.0). For the healthy 
individuals group, mean OB volumes for the selected OBs were 47 mm3 and 45 
mm3 for the first and second series, respectively, while it was 53 mm3 and 52 mm3, 
respectively, for the PD group. The mean OB volumes for the selected OBs did 
not differ between groups for neither series (p=0.14, p=0.19).  
In healthy individuals mean FA for the selected OBs was for the first and 
second series 0.22 and 0.20, respectively, while it was for PD patients 0.16 and 0.18, 
respectively. For healthy individuals mean MD for the selected OBs was for the 
first and second series 1.5×10-3 mm2/s and 1.4×10-3 mm2/s, respectively, while it 
was for PD 1.7×10-3 mm2/s and 1.5×10-3 mm2/s, respectively. CV for mean FA 
was 15% and for mean MD 11%. Measurements showed significant differences for 
the selected OBs between healthy individuals and PD patients in the first series, 
both on FA (p<0.001) and MD (p<0.01), but not in the second series, neither for 
FA (p=0.36) or MD (p=0.58). 
For healthy individuals mean FA for SN was for the first and second series 
0.41 and 0.40, respectively, while it was for PD patients 0.37 and 0.36, respectively. 
Measurements showed significant differences for SN in both series on FA (p<0.01, 
p<0.05). For healthy individuals mean MD was for the first and second series 
0.79×10-3 mm2/s and 0.77×10-3 mm2/s, respectively, while it was for PD patients 
0.82×10-3 mm2/s and 0.80×10-3 mm2/s, respectively. No significant differences 
were seen in MD on neither series (p=0.50, p=0.30). CV for both mean FA and 
mean MD was 5%. 
For healthy individuals mean FA for CC was for the first and second series 
0.66 and 0.64, respectively, while it was for PD patients 0.65 and 0.64, respectively. 
For healthy individuals mean MD was for the first and second series 0.85×10-3 
mm2/s and 0.87×10-3 mm2/s, respectively, while it was for PD patients 0.87×10-3 
mm2/s and 0.87×10-3 mm2/s, respectively. Measurements showed no significant 
differences for CC between healthy individuals and PD patients in both series for 
FA (p=0.33, p=0.77) and MD (p=0.07, p=0.83). CV for mean FA was 3% and for 
mean MD 2%. 
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4.5 THE ‘HUDDINGE SPINOCEREBELLAR ATAXIA FAMILY’ – 
 MRI ANALYSIS OF BRAIN, SPINAL CORD AND PERIPHERAL 
 NERVE 
In Study V of a peripheral nerve, one patient (#2) was excluded since the 
distal thigh was too bulky to fit into the coil, due to a high amount of subcutaneous 
tissue. One patient (#3) had its division of the sciatic nerve, into the common 
peroneal and tibial nerve, proximal on the thigh and therefore the broader tibial 
nerve was examined. In the other two participants the sciatic nerve was examined. 
In all three studied patients maximum FA was lower than for the healthy controls, 
which was significant (p<0.01) (Figure 21, Table 2). 
 
 
 
 
 
SCA Control SARA correlation 
mesencephalon 0.33±0.01% 0.35±0.03% 0,22 
pons 1.20±0.13% 1.58±0.12% -0,68 
medulla oblongata 0.35±0.05% 0.50±0.04% -0,75 
cerebellum 9.25±0.68% 11.48±0.47% -0,62 
spinal cord 5.5±0.4 mm 6.7±0.3 mm -0,69 
peripheral nerve max FA 0.45±0.01 0.57±0.04 -0,97 
peripheral nerve MTR 14±7% 18±3% 0,25 
muscle MTR 39±1% 40±1% 
  
Table 2. Data for the SCA group and control group. MRI volumetry showing the percentage of total brain 
volume for mesencephalon, pons, medulla oblongata and cerebellum. Mean midsagittal diameter for the 
spinal cord. Maximum FA and MTR for a peripheral nerve. MTR for muscles. Correlation of patient MRI 
measurements with SARA scores. 
 
No significant difference (p=0.36) was seen in mean MTR between the 
three patients and the healthy controls (Table 2). For comparison, MTR was 
calculated for the vastus medius muscles. No significant difference (p=0.22) was 
seen in mean muscle MTR between the three patients and the healthy controls 
(Table 2). 
 
4.5.1 Clinical details, ENeG, brain and spinal cord volume alterations 
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In Study V all patients had clinical signs of cerebellar ataxia, symmetric PNP, 
areflexia/severe hyporeflexia, dysautonomia symptoms (varying degree of 
orthostatism, syncope and erectile dysfunction) and dysarthria. None of the 
patients had reduced visual acuity, behaviour disturbances, cognitive decline, 
deafness or extrapyramidal symptoms (i.e. bradykinesia, resting tremor, dystonia or 
involuntary movements). SARA scores are presented in Table 1. All controls were 
normal on neurological investigation. 
ENeG showed that: 
Patient#1 had a normal motor conduction of the right tibial nerve, but no 
registration was found in the right sural nerve. These findings are compatible with 
axonal sensory neuropathy. 
Patient#2 had a somewhat low amplitude distal muscle response on 
stimulation and slightly decreased motor conduction speed of the left tibial nerve. 
No registration was found in the left sural nerve. These findings are compatible with 
a sensorimotor neuropathy, which is predominately axonal and somewhat more 
pronounced for sensory nerve function. 
Patient#3 (index case) had a somewhat low motor conduction speed, highly 
decreased distal latency, highly decreased response amplitude and F-response with 
delayed latency of the right tibial nerve. These findings are compatible with a 
moderate motor neuropathy, most probably axonal neuropathy. 
Patient#4 had a normal motor conduction of the right tibial nerve. Normal 
conduction speed with very low amplitude response was found in the right sural 
nerve. These findings are compatible with axonal sensory neuropathy. 
A sural nerve biopsy in patient#1 showed moderate loss of myelinated 
fibers, both of large and small fibers. No inflammatory cells were found. 
MRI volumetry showed in all patients that pons, medulla oblongata, and 
cerebellum were significantly smaller (p<0.005, p<0.01, p<0.005) in percentage of 
total brain, than in the healthy controls (Table 2, Figure 22). For mesencephalon 
there was no significant difference (p=0.15, Table 2), although the trend was a 
smaller mesencephalon in patients compared with healthy controls (three patients 
had a smaller mesencephalon). As a consequence of a smaller pons, medulla 
oblongata and cerebellum, and normalisation to total brain volume, the cerebrum 
was significantly (p<0.005) larger in the patients. No significant difference (p=0.87) 
was seen in total brain volume. In all patients the mean midsagittal spinal cord 
diameter was significantly smaller (p<0.05) than in the healthy controls (Table 2, 
Figure 23). 
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Conventional MRI of the brain showed no infarcts, haemorrhages or 
tumours. Minor degenerative periventricular white matter changes were seen in one 
patient (#3) and one control (#1). One control (#4) had a small pineal cyst. The 
pons was evaluated for the ‘hot cross bun’ sign66, which none of the participants 
had. No focal changes were seen in the spinal cord. In one patient (#1) fat atrophy 
was noted in the semimembranosus and biceps femoris longus muscles. 
Correlations of SARA scores with MRI measurements are shown in Table 2. 
There was a high negative correlation of SARA scores with the volume of pons, 
medulla oblongata, cerebellum and maximum FA of a peripheral nerve. 
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5. DISCUSSION 
 
5.1 NERVE DIFFUSION TENSOR IMAGING 
Study I 
Study I was the first published study (2004) to show that human peripheral nerves, sciatic nerves, 
could be visualised in vivo using DTI and fiber tracking, despite the diffusion technique’s inherent 
difficulties with low SNR, sensitivity to patient motion, field inhomogeneities and fast T2 relaxation. 
DWI and DTI are techniques suffering from a low SNR and low spatial 
resolution16,17. Due to the faster T2 relaxation (surrounding muscles) and 
consequently a lower SNR67, PNS can be more difficult to image than the CNS. 
According to Eq. [4], a higher b-value will produce more echo attenuation, thus 
lower SNR68. However, decreasing the b-value to increase SNR will decrease the 
amount of diffusion-weighting69. For SNR reasons a b-value of 400 s/mm2, i.e. in 
the lower range, was chosen in Study I. Since the signal intensity is proportional to 
the voxel volume70, the peripheral nerve with the largest transaxial diameter, the 
sciatic nerve, was examined and the voxel size was 2.5×2.5×6.0 mm. Subsequent 
studies examining the median nerve, have for fiber tracking established an optimal 
b-value of 1025 s/mm2 at 1.5 T69 and between 1000-1400 s/mm2 at 3 T71. There is 
no general agreement on what b-value to use for brain imaging, although a similar 
b-value of 1000 s/mm2 is recommended14,15,72. However, and important, comparing 
studies with different b-values is problematic since the trace, MD and FA all 
depend on the b-value72,73. To estimate the tensor in DTI, at least six non-collinear 
diffusion-encoding directions and one without diffusion-weighting, or a very low b-
value, is needed15. To further improve SNR, NSA can be increased or extra 
diffusion-encoding gradient directions used. Doubling NSA or gradient directions 
will have the same effect on the scanning time15,74. In Study I 32 diffusion-
encoding directions were used. According to a simulation study, a minimum of 30 
directions is recommended for a good tensor orientation estimation15. As long as 
the diffusion directions are well balanced, comparing studies with different 
diffusion-encoding gradient schemes is feasible74. 
A single-shot diffusion-weighted EPI sequence was used in Study I, due to 
its fastness and simplicity, although other sequences can be used, e.g. a multi-shot 
diffusion-weighted EPI sequence68. Since the entire k-space is filled in one instance, 
the single-shot EPI sequence is relatively insensitive to patient motion, which is 
more problematic outside the CNS15,67. However, the limitations are many, e.g. a 
low spatial resolution due to T2* relaxation during the acquisition. It is also 
sensitive to magnetic field inhomogeneities, chemical shift and susceptibility effects 
(off-resonance effects) due to a narrow bandwidth in the phase-encoding direction. 
Finally, there are geometric distortions due to susceptibility effects and eddy 
currents15,68,75.  
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The bipolar diffusion-encoding gradients have a high magnitude and long 
duration, which results in eddy currents. Eddy currents will result in residual small 
gradient fields interfering with the read-out gradient and thereby causing spatial 
distortion. If the eddy current effects are not cancelled or reduced, they will result 
in considerable image distortion. These artifacts can be reduced with a twice-
refocused spin echo pulse, instead of the conventional diffusion pulse76. This pulse 
is vendor-dependent and was not available on the Philips MR-scanner in Study I, 
II, III and IV, but available on the Siemens MR-scanner and was used in Study V. 
If the twice-refocused spin echo pulse is used or not, can contribute to a variation 
in diffusion data when comparing between different MR-scanners77. The twice-
refocused spin echo pulse may slightly increase TE and reduce SNR15,75. 
Several methods exist to visualise DTI data78. One method is fiber tracking, 
which is a 3-dimensional method using algorithms to construct ‘fibers’ and has 
been validated in human post-mortem tissue29,79. Isotropic voxels are preferable, 
although not necessary33,80. It uses tensor anisotropy information, i.e. FA and tensor 
orientation characteristics, to construct fibers. A starting point, i.e. a seed point, is 
selected and a propagation line (the fiber) is created if the defined criteria for 
iterative propagation are fulfilled, i.e. the largest fiber deviation, minimum fiber 
length, step size and anisotropy threshold29. All these criteria are user-selected and 
will affect the end result80, which will also be affected by noise and the seed point 
size81. With these iterative propagation techniques, noise errors accumulate as the 
propagation becomes longer82. Even the location of the seed point within a voxel 
can significantly affect the end result. Multiple ROIs can be selected with the 
criterion that fibers have to pass through them80, which was used in Study I. The 
vast different algorithms available will also affect the result30,80. However, one study 
analysing the median nerve83, showed moderate to substantial correlation between 
two software packages. Altogether, this makes quantitative measurement with fiber 
tracking difficult. In brain fiber tracking the variability can be reduced by increasing 
the diffusion-encoding directions from 15 to 30, and accuracy can be improved by 
increasing NSA from 1 to 284. 
 
 
Study II 
Study II showed that peripheral nerves, sciatic nerves including their division into the tibial and 
common fibular nerves, have a characteristic diffusion pattern. This allowed nerves, excluding other 
tissues and artifacts, to be visualised using a novel approach called DDI and also with a simple 
unidirectional diffusion MIP approach. 
A limiting factor in the tensor model is that the largest eigenvector, i.e. the 
nerve fiber direction, is in the direction of the largest signal attenuation and thereby 
most sensitive to a low SNR19,21. In Study II the diffusion-encoding gradient 
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directions were designed as a fan, and as expected the least signal attenuation was 
perpendicular to the nerve direction (Figure 15 and 24). 
 
 
 
Figure 24. The long arrow indicates the sciatic nerve in an axial slice. The short arrow indicates a vessel. A) 
T1-weighted anatomical reference. B) DWI with diffusion-encoding direction perpendicular to nerve 
(direction 18). C) DWI with diffusion-encoding direction parallel to nerve (direction 36). L: Left; P: 
Posterior. 
 
This information was used for nerve visualisation by using a simple 
unidirectional diffusion MIP approach (Figure 19A, B). The use of unidirectional 
diffusion MIP has subsequently been found feasible in studies evaluating the sacral 
plexus and peripheral nerves85,86. In a post-processing technique called ‘soap-bubble 
MIP’, user-defined curved ROI volumes were used to delineate the sacral plexus 
from surrounding tissues, e.g. the bone marrow and lymph nodes85. 
By using DDI it is possible, without manual ROI techniques, to image the 
nerves, while suppressing other tissues as vessels, artifacts and muscles (Figure 
19C). In Study II, a high b-value of 1000 s/mm2 also contributed to suppressing 
muscle, which is used in ‘diffusion-weighted whole body imaging with background 
body signal suppression’87. The diffusion curves do not entirely reflect diffusion, 
since there is an exponential decay of the MR signal. However, due to the simplicity 
of the post-processing method in DDI, this was not compensated for when 
separating perpendicular diffusion from parallel diffusion in the nerves. 
SENSE, a parallel imaging technique88, was used in Study II. Phase-
encoding is time consuming and with parallel imaging fewer lines in k-space can be 
collected. The distance between the phase-encoding lines is increased, while the 
spatial resolution is kept the same. This introduces aliasing, which can be removed 
by using the phased-array coils varying spatial sensitivities. The acquisition speed is 
increased by an acceleration factor, e.g. a factor of two shortens the time by the 
same factor, since half of the phase-encoding lines in k-space are sampled88. The 
acceleration factor can as a maximum assume the number of elements used in the 
phased-array coil, although acceleration factors between 1.5 and 3 are normally 
used15,88. In images acquired with parallel imaging techniques, noise is located more 
in the image center than in the periphery, clearly more evident in higher accelerated 
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images88,89. Parallel imaging reduces susceptibility artifacts by increasing the phase-
encoding speed in k-space90, reduces image blurring68 by filling the outer k-space 
with higher SNR where the details are collected and increases SNR by reducing 
TE17,91. Best SNR efficiency for an eight-element head coil was reported with a b-
value of 1000 s/mm2, an acceleration factor of 2.1 and partial Fourier encoding of 
60%17. An additional study has reported an acceleration factor of 2 as better than 
acceleration factors zero, 3 or 4, both quantitatively and qualitatively92. 
Reducing pulsation artifacts with cardiac gating has been proposed12, 
although this was not used in Study II, since it would have prolonged an already 
long sequence. Regional saturation technique (REST) has been used in peripheral 
nerve DTI studies to minimise flow artifacts93. REST is a saturation band, which at 
its location applies a 900 RF pulse directly prior to the imaging sequence RF pulse70. 
REST slightly prolongs TR and it was tested in one individual. There was no 
obvious improvement and was not used in Study II, although it was not 
thoroughly exploited (Figure 25). 
 
 
 
Figure 25. Coronal view of DDI images without (A), and with regional saturation technique (REST) (B). 
L: Left; F: Feet. 
 
 
Study III 
Study III was the first published study to show that OB and olfactory tracts could be visualised in 
vivo using DTI and fiber tracking, despite localised in an area prone to susceptibility artifacts. 
OBs and olfactory tracts are anatomically close to air-filled sinuses and 
bone, and therefore exposed to susceptibility artifacts7,94. The direction of these 
artifacts depends on the phase-encoding direction. In conventional EPI sequences, 
k-space is sampled with a rectangular/Cartesian approach. K-space is traversed 
from top to bottom or the reverse (Figure 9), thus with positive or negative phase-
encoding blips75,91. By employing the phase-encoding direction anterior-posterior 
(‘fold-over direction’; Philips) and using negative phase-encoding blips (‘fat-shift 
direction anterior’; Philips) artifacts were displaced posterior and not at the location 
of the OBs (Figure 26A), which was used in Study III and IV. 
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Figure 26. Arrow pointing at an artifact displaced posterior (A) and anterior (B). R: Right; ANT: Anterior; 
L: Left; P: Posterior. 
 
With positive phase-encoding blips, the OBs were obscured by the artifacts 
(Figure 26B). In functional MRI it is also important, depending on the area of 
interest, to traverse k-space in different directions95. To reduce geometric distortion 
there are techniques that would be of interest to exploit in this location, e.g. 
acquiring and combining k-space in reverse directions or measuring the b-zero field 
for a retrospective correction33,72. 
The MR signal is continuous, but sampled in a discrete manner. According 
to the Nyquist theorem, the minimum sampling that is needed to correctly display 
the frequency are two equally spaced samples acquired within one cycle of the 
highest frequency component70. The receiver bandwidth is the range of the 
sampling frequency and is inversely proportional to the sampling interval, thus 
doubling the sampling interval will reduce the receiver bandwidth by half. 
Consequently, it will be narrower, but with a longer sampling time and longer TE96. 
If the sampling rate is fixed and the frequencies are lower, the time has to be 
prolonged in order to sample enough according to the Nyquist theorem. Noise is 
random and distributed uniformly over the whole bandwidth, and since a narrow 
receiver bandwidth does not sample high frequencies, this will result in a higher 
SNR. Noise is proportional to the square root of the bandwidth, albeit with a 
narrow receiver bandwidth the minimum TE can be longer, which also affects 
SNR70. Artifacts will be displaced for a longer distance with a narrow receiver 
bandwidth. Thus, a receiver bandwidth of 1000 Hz and 10 pixels in one direction 
will yield 100 Hz/pixel, while a wider receiver bandwidth of 10000 Hz and again 10 
pixels in one direction will result in 1000 Hz/pixel. A wide receiver bandwidth 
(‘water-fat-shift minimum’; Philips) was used since k-space is traversed faster, i.e. 
shorting the sampling time, which results in less distortion. In single-shot EPI the 
sampling interval is long in the phase-encoding direction, consequently the 
bandwidth is narrow. Small frequency differences due to inadequate shimming, 
chemical shift and susceptibilities will therefore have large displacement in this 
direction, i.e. large image distortion effects91. 
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Eddy-currents also contribute to artifacts. Even if eddy-current correction is 
used to lessen the effect and artifacts are displaced from the area investigated, the 
misregistration artifacts still contribute to all voxels in the acquired data72. Different 
techniques exist to traverse the phase-encoding direction faster, which would 
reduce the artifacts, and are of interest to explore in this anatomical location, e.g. 
PROPELLER, Propeller EPI in the other direction and read-out segmented 
EPI75,97-99. The PROPELLER technique utilises oversampling of central k-space for 
self-navigation, i.e. motion correction, which will cause longer scanning times15. 
Multi-shot imaging is somewhat problematic in DTI, since all of the k-space is not 
acquired at the same time. Any minimal motion between the shots introduces 
artifacts and single-shot techniques are currently predominant91. 
Eddy current distortions are seen as three types of geometric distortion; 
scaling, translation and shear11,72. Eddy current distortions and simple motion can 
to some extent be corrected with post-processing. There are several different 
software programs and vendor-specific algorithms available. FSL provides an affine 
registration using 12 degrees of freedom, aligning each slice’s diffusion-weighted 
images to its reference image/b-zero, regardless of eddy current artifacts or patient 
motion. This was used in Study III and IV (http://www.fmrib.ox.ac.uk/fsl). 
However, correcting for large motion is harder, and motion occurring in the z-axis 
is not corrected for, since the reference image could partially or fully be a different 
b-zero. The strong diffusion-encoding gradients also cause low-frequency 
mechanical resonance vibrations of the patient table, contributing to motion 
artifacts100. Measuring motion can be complicated, especially since there often is 
during long examinations a small anatomical drift summarised to a larger 
distance101, albeit new motion correction techniques are evolving. One study used a 
camera to optically analyse head movement102 and another study utilised a 
retrospective approach for image reconstruction103. The issue of motion is often 
neglected in published clinical papers, and during the lengthy DTI sequence in 
Study IV there was a considerable exclusion owing to motion. Due to head 
movement during an acquisition, there is in ROI analyses a positive bias in MD, 
and just removing images with large artifacts is insufficient104. Prior to post-
processing in Study IV, the diffusion-weighted images were visually analysed for 
head movements in three reconstructed planes. B-matrix reorientation was 
performed after eddy current/motion correction101. Theoretically this should be 
performed on data after an affine registration using 6 degrees of freedom, i.e. only 
motion, since eddy currents effects are random. B-matrix reorientation was still 
used. However, participant motion was excluded visually and the reorientation 
effect was thereby minor. 
The OBs are small and the reconstructed voxel sixe in Study III and IV was 
0.9×0.9×3.0 mm. SNR is important in DWI and DTI16, and SNR α √NSA96. The 
small voxels will decrease SNR and as compensation, four NSA was used and the 
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b-value was slightly shortened, 900 s/mm2 as compared to 1000 s/mm2 for 
standard brain protocols14,15. Although 3.0 T MR-scanners provide more SNR than 
1.5 T, the susceptibility artifacts are more severe due to the faster T2* 
relaxation15,35,105. To reduce geometric warping, i.e. artifacts from off-resonant spins 
or susceptibility artifacts, TE should be kept short15,68,105. This can be achieved by 
using maximum diffusion-encoding gradient strength/slew rate, ramped sampling, 
parallel imaging and partial Fourier encoding17,92,96. Higher resolution, i.e. smaller 
voxels, will reduce susceptibility artifacts70. Reporting SNR in studies could be 
considered89. SNR can be measured in several ways, the simplest is using a ROI in 
the acquired image, e.g. measuring the mean signal intensity in the mean diffusion-
weighted image (i.e. all diffusion encoded directions) or in the mean b-zero image, 
divided by the SD of the noise in the image background89, sometimes using a 
correction factor69. One b-zero (or low b-value) image for every 5-10 diffusion-
weighted image is considered optimal106,107, which was not possible with the MR-
scanners15 used in Study I-V. In ‘high-FA’ regions (approximately FA 0.80) a SNR 
of 20 is recommended, in ‘medium-FA’ (approximately FA 0.45) a SNR of 40, and 
in ‘low-FA’ regions (approximately FA<0.20) SNR 50 at 1.5 T and SNR 70 at 3.0 
T33,89. Two studies of the median nerves69,108, using a b-value of 1025 s/mm2, 
reported a SNR of 56 and 59 at 1.5 T. A low SNR can cause a bias in FA, which 
can vary with different factors, e.g. what region of the brain is examined, head size, 
hardware and software33,89,109. With a low SNR an upward FA bias is seen110. 
Changing the number of diffusion-encoding gradient directions, NSA or voxel size, 
and thereby affecting the SNR, can cause intra-individual FA differences111.  
Fiber tracking was used in Study III to visualise OBs and olfactory tracts. 
The proximal portion of the olfactory tracts could rarely be fiber tracked, since the 
tracts split up into fibers with very thin diameters, compared to the DWI axial slice 
diameter. As a negative control a patient with congenital anosmia was examined, 
where neither OBs nor olfactory tracts were seen on T2-weighted nor the fiber 
tracking images. For fiber tracking, FA threshold was 0.18 in Study III, similar to 
previous fiber tracking studies of other cranial nerves112,113. 
 
 
Study IV 
Using a novel approach for more objective ROI placement, altered diffusion was found in OBs in 
the PD group, as compared to healthy individuals. However, the intra-individual variability was 
high, due to OBs small size and location susceptible to artifacts, and the difference between the 
groups was significant only for the first of two series. 
OBs are small and therefore a time-consuming high spatial resolution MRI 
sequence was used. Since OBs are located in a region susceptible to artifacts, the 
intra-individual variability was tested by performing two identical DTI sequences 
and CV was calculated. Prior to eddy current/motion correction, diffusion-
weighted images were visually analysed for head movements in three reconstructed 
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planes. Several participants had to be excluded due to head movements, since even 
a small head movement would affect the measurements. Hyposmia is noted early in 
PD9 and olfaction impairment was clearly evident in the 14 PD patients included 
(and the 4 excluded) in Study IV. OB volume was measured, since smaller OB 
volumes would result in more partial volume effects, which could otherwise falsely 
explain a diffusion difference. No difference was found between PD patients and 
healthy individuals for the selected OBs. Another study53 similarly found that the 
OB volume was not different in PD patients compared to healthy controls. The 
measures of the OBs’ transaxial diameters and lengths in Study IV were similar to 
reported data8. At a b-value of 1000 s/mm2, white and grey matter have similar 
trace, despite a high difference in FA72. Contribution of cerebrospinal fluid will 
increase MD (trace/3). MD was similar in SN and CC, while increased MD was 
seen in OB, due to the partial volume effect of cerebrospinal fluid. 
Even if DTI is corrected for eddy currents and minor motion, small 
anatomical residual distortions still remain. Due to the diffusion technique’s local 
misalignment artifacts, it is suboptimal for ROI placement to solely depend on a 
non-diffusion anatomical sequences and even a b-zero image72. The OB’s small size 
and location susceptible to artifacts cause a high user-dependent ROI placement 
variability, making DTI measurements in these regions challenging. Since the left 
and right OBs often are situated slightly different in the superior-inferior axis 
(Figure 16A), both were not to an equal extent included in the axial 3 mm DTI 
slice. For example, if one OB is divided between two axial slices, using a regular 
ROI anatomical placement technique, it would actually measure the diffusion in 
two consecutive axial slices, i.e. in a 6 mm superior-inferior axis. Given these 
difficulties, a novel approach in which ROI placement not only relies on anatomical 
data but also on the inherent diffusion directional information in DTI was used. 
Each ROI was placed in only one slice in the location of each OB, in which the 
diffusion was highest in an anterior-posterior axis correlating to their anatomical 
direction. Due to partial volume effects, only the ROI with the smallest αy angle 
was used for analysis in each individual, since the side with higher αy angle is not 
likely to fully represent the OB. Tilting of the axial diffusion slices in a left-right 
plane to cover both OB would have allowed comparison of left and right OB 
diffusion. However, this was not possible since the post-processing diffusion steps 
required non-tilted slices. In addition, would it have made placement of the SN 
ROIs more difficult. In the PD group, compared to healthy individuals, FA was 
decreased and MD increased in the OBs. However, the intra-individual variability 
was high in OBs, owing to their small size and location susceptible to artifacts, and 
the difference between the groups was significant only for the first of two series. 
Moreover, a low SNR could contribute89. In OB the CV was 11-15%, while it was 
in SN 5% and in CC 2-3%. Similar CVs have been reported, with smaller variations 
in major white matter and larger in grey matter114. Diffusion alterations were 
hypothesised, since α-synuclein inclusions and Lewy neurites interfering with nerve 
structure have been detected in OBs9. Even though diffusion was only measured in 
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one of each patient’s OBs, UPSIT showed highly significant olfaction impairment 
in the PD group and close to normal scores in the healthy individuals. Thus, the 
diffusion differences could therefore hardly be explained by a unilateral OB 
involvement. Similar alterations in FA and MD have also been found in a study on 
optic neuritis115. In a study using anatomical ROI placement, diffusion alterations 
were found in ‘the anterior olfactory structures’116 and in a study using voxel-wise 
group statistical analysis, diffusion alterations were found in the ‘location of the 
olfactory tracts’49. In idiopathic REM sleep behaviour disorder, a risk marker for 
PD, a voxel-wise group statistical analysis found diffusion alterations in the 
‘olfactory region’117. Even though the diffusion alterations could not be reproduced 
in the second series, this could be due to a minimal difference in head position, 
which would produce other partial volume artifacts (Figure 16A). Another 
contributing factor could be the fewer participants in the second series, since the 
trend for mean FA and mean MD was similar to the first series. The second series 
comprising fewer participants could reflect the problem of remaining motionless 
for a prolonged time period. 
In the two DTI series in Study IV the mean smallest αy angle in OBs was 
similar in the PD group and healthy individuals, indicating that although FA is 
decreased in PD patients, the tensor is still directed along the OBs. In late-stage 
PD, OBs can theoretically have α-synuclein inclusions and Lewy neurites to the 
degree that FA is very low or the tensor is no longer aligned along the OB, and 
thereby not depicted by the approach used in Study IV. Since olfaction often is 
impaired prior to motor symptoms in PD, it would be of interest to use imaging of 
the OBs as a biomarker for early diagnosis44,45,116. It may turn out that diffusion 
changes in the OBs occur prior to olfaction impairment. Since the degree of 
hyposmia already is high in early-moderate PD, an imaging biomarker rather than a 
smell test, may be superior to monitor disease progression. Diffusion alterations 
have also in PD patients been demonstrated in white matter adjacent to central 
olfactory cortex, suggesting that changes in several brain regions underlie olfaction 
impairment in PD118. In functional MRI the inter-individual variation in activation 
of main olfactory areas is high and therefore hard to use as a diagnostic tool in the 
individual patient119. 3.0 T and 9.4 T in vitro conventional MRI studies of the OBs 
can identify lamination8, i.e. the cellular layers, which would be interesting to 
evaluate in PD. 
 
 
Study V 
Using DTI to study SCA patients with ENeG confirmed PNP, a significant FA reduction was seen 
in peripheral nerves, compared to healthy controls.  
Since the bandwidth in EPI is narrow in the phase-encoding direction, 
chemically shifted signals from fat will be displaced several pixels in the phase-
encoding direction, causing artifacts. Fat suppression is therefore compulsory70. 
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Study V was performed at 3.0 T and at this higher field strength, fat suppression is 
more problematic. This is due to RF inhomogeneities, since the wavelength is 
reduced35,70,120. SPAIR, an adiabatic pulse, was used for fat suppression, since it is 
more robust than SPIR to RF inhomogeneities70. Additional fat suppression with 
REST was applied on subcutaneous tissue. 
In EPI, Nyquist ghosting artifacts can be seen. EPI uses strong gradients and 
residual eddy currents in electrically conductive MR-scanner structures are 
common. The residual eddy currents can lead to mistiming of gradient amplitudes 
and temporal shifts in the read-out direction. Using Cartesian k-space sampling, 
this will result in small lateral shifts for the different directions, i.e. Nyquist 
ghosting artifacts in the phase-encoding direction. The artifacts resemble foldover 
artifacts91. To reduce Nyquist ghosting artifacts, a reference scan and shimming are 
performed70. Since SNR is important, a transmit/receive 15-channel knee coil with 
an inner diameter of 154 mm was used to examine the distal thigh in Study V. Due 
to the inner diameter, one of the patients could not be examined, since the distal 
left thigh could not fit into the coil. The other three patients were examined and all 
had a lower maximum FA in the nerves compared to the healthy controls. 
Although MRI was performed on the left sciatic nerve/tibial nerve and ENeG on 
the right tibial nerve, all patients had clinical signs of symmetric PNP and 
neuropathy was confirmed by ENeG. In one of the patients, fat atrophy was noted 
in the semimembranosus and biceps femoris longus muscles. These findings 
support neuropathy121, since these muscles are innervated via the tibial part of the 
sciatic nerve. 
SARA is a validated rating scale for ataxias with a good inter-rater 
reliability60. In SCA1, 2, 3 and 6, SARA scores of ataxia symptoms have been found 
to correlate with MRI volumetry of the brainstem and cerebellum57. In Study V 
there was a high negative correlation of SARA scores with the volume of pons, 
medulla oblongata and cerebellum. The highest negative correlation was seen with 
maximum FA of a peripheral nerve. Nerve diffusion tensor imaging performed 
with high precision and accuracy could be a promising potential biomarker of PNP. 
In an ex vivo high-resolution DTI study on mice, FA was decreased in axonal 
degeneration of peripheral nerves and also correlated with the total number of 
regenerating axons122. In a study on experimental contusion injuries in rat sciatic 
nerves, FA correlated more with axon density and diameter, than with myelin 
density and thickness. In the same study, FA was found to correlate with changes 
in histology and function123. In SCA1 and SCA2, decreased FA has been found in 
the brain and correlated with clinical symptoms58,124. 
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There are several studies measuring FA in peripheral nerves, both on normal 
nerves and on nerves with pathology69,125-137 (Table 3). 
 
aFT Study bT cb Nerve   HI P HI/P 
            Max. FA measured Max. FA measured   
No Kakuda125 et al 3 1000 Tibial Group median FA 0.53 d0.40 10/10 
No Skorpil et al [Study V] 3 1000 Sciatic/tibial -ıı- e0.57 f0.45 3/4 
No Tanitame126 et al 3 1000 Tibial -ıı- g0.52 gh0.44 26/22 
No Hiltunen127 et al 3 1000 Tibial (knee) -ıı- 0.85 - 3/0 
No -ıı- 3 1000 Peroneal -ıı- 0.79 - 3/0 
No -ıı- 3 1000 Tibial (ankle) -ıı- 0.73 - 3/0 
No -ıı- 3 1000 Median -ıı- 0.74 - 4/0 
No -ıı- 3 1000 Ulnar -ıı- 0.67 - 4/0 
No -ıı- 3 1000 Radial -ıı- 0.62 - 3/0 
            Mean FA measured Mean FA measured   
No Tagliafico128 et al 3 1000 C5-C8 Group median FA 0.33 - 40 
            Mean FA measured Mean FA measured   
No Guggenberger129 et al 3 1200 imedian Group mean FA k0.59 kl0.53 45/15 
No -ıı- 3 1200 mmedian -ıı- k0.54 kl0.44 45/15 
No -ıı- 3 1200 nmedian -ıı- k0.48 kl0.42 45/15 
Yes Hiltunen130 et al 3 1000 Median -ıı- o0.48/e0.42 l0.42 12/12 
Yes Kabakci131 et al 3 1000 Median -ıı- 0.71 l0.43 20/2 
No -ıı- 3 1000 pMedian -ıı- 0.59 - 20/0 
No -ıı- 3 1000 rMedian -ıı- 0.72 - 20/0 
No -ıı- 3 1000 sMedian -ıı- 0.71 - 20/0 
No Jambawalikar132 et al 3 1000 Ulnar -ıı- 0.75 - 10/0 
No Yao133 et al 3 600 tMedian -ıı- 0.70 - 13/0 
Yes van der Jagt134 et al 3 800 L4-S3 -ıı- 0.26 - 10/0 
Yes Balbi135 et al 1.5 900 L5 or S1 -ıı- 0.22 u0.19 19/19 
No Vargas136 et al 1.5 900 C5-C8 -ıı- 0.30 x0.24 6/11 
No Andreisek69 et al 1.5 1025 pMedian -ıı- 0.50 - 15/0 
            Mean FA measured Mean FA measured   
Yes Khalil137 et al 1.5 400 Median Group median FA e0.59 l0.53 13/13 
 
Table 3. FA values in peripheral nerves in different studies. Healthy individuals (HI) and patients (P). 
a
Fiber tracking derived FA values. 
b
Tesla. 
c
b-value (s/mm2). 
d
Chronic inflammatory demyelinating 
polyradiculoneuropathy. 
e
Age-matched. 
f
Spinocerebellar ataxia. 
g
Age-corrected. 
h
(17 Chronic inflammatory 
demyelinating polyradiculoneuropathy, 3 Charcot-Marie-Tooth disease, 1 Guillain-Barré syndrome, 1 
Churg-Strauss syndrome). 
i
DRU-level. 
k
Both readers. 
l
Carpal tunnel syndrome. 
m
Pisiforme-level. 
n
Hamatum-level. 
o
Young controls. 
p
Flexor retinaculum. 
r
Wrist level. 
s
Forearm level. 
t
Within carpal tunnel. 
u
Compressed root. 
x
At level of pathology. 
 
The reported measures differ between studies, FA-values are derived from fiber 
tracking results or ROI analyses, and either the maximum or mean nerve FA was 
reported (Table 3). Since peripheral nerves are small in diameter, there is a potential 
risk that a ROI includes other tissues, e.g. muscles and fat, which have lower FA 
than nerves14. Consequently, maximum FA is preferable compared to mean FA, 
which was measured in Study V and in other studies125-127. In the statistical 
comparisons between groups, either the median or mean FA was reported (Table 
3). Two studies have only illustrated FA-values in tables93,138. According to the 
studies presented in Table 3, maximum FA range in healthy individuals was 0.52-
0.85 and mean FA range was 0.22-0.75. FA values decrease with age and ADC 
increases126,129,131, although this was not found in one study133. A reduction of FA 
values with age has also been observed in the brain139. Histopathological studies 
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have shown age-related changes in peripheral nerves, i.e. degeneration of myelin 
sheaths, axon deletion, microtubule changes and increasing interstitium, which 
could be a cause of the age-related diffusion changes129. FA values also decrease 
with a smaller nerve size127. Two studies have shown that FA decreases distally in 
the median nerve129,131, while another study did not133. FA and ADC does not 
correlate with gender126,129,133, and no intra-individual side difference has been 
observed in median nerves at wrist level or nerves in forearms93,108,133. 
A high inter-reader129 and high inter- and intra-reader agreement137 have 
been reported in studies conducted on median nerves. However, the variance in 
normative data of the median nerve differs between studies, with low variance in 
one study129 and higher in other studies108,131,133. A low variance is necessary to 
implement DTI in the clinical setting and the technique is challenging due to 
several reasons, e.g. field homogeneities, gradients and SNR129,133. Internal control 
of the contralateral nerve could be helpful in data interpretation108,130. On repeated 
examination, three weeks apart, the reproducibility was high108. For nerve 
evaluation, quantitative DTI measurement is preferred to qualitative fiber 
tracking30,80-82,108, nevertheless studies on optimisation of fiber tracking of median 
nerves have been performed. At 3.0 T the recommended parameters are a b-value 
of 1000-1400 s/mm2, a minimum FA threshold of 0.2 and a maximum angulation 
of 10 degrees71. At 1.5 T69 the recommended b-value is 1025 s/mm2. 
In all studies presented in Table 3, FA was decreased in patients, except in 
one study on carpal tunnel syndrome130. Several studies have focused on carpal 
tunnel syndrome129-131, while another disease that has been investigated is chronic 
inflammatory demyelinating polyradiculoneuropathy125, which in another study 
included Charcot-Marie-Tooth disease, Guillain–Barré syndrome and Churg–
Strauss syndrome126. In Study V SCA patients, with clinical signs of PNP and 
ENeG verified PNP, were examined. In the three studied patients, maximum FA 
for a peripheral nerve was significantly lower than for the healthy controls (Table 
2). A sural nerve biopsy in one of the patients showed moderate loss of myelinated 
fibers, both large and small fibers, with no inflammatory cells. In sciatic neuropathy 
conventional MRI may be helpful140 and DTI is a promising complement in 
peripheral neuropathy141. In the brachial plexus, FA has been evaluated at the level 
of compressing neoplasms, although no statistical difference was found compared 
to healthy individuals136. However, decreased FA has been seen in compressed 
lumbar nerve roots135. FA is lower in normal nerve roots134,135 than in other nerves. 
Possible explanations could be that spinal root nerve endoneurium contains much 
less collagen and a partial volume effect134,135. 
In Study V, the maximum FA was registered. As mentioned in a study by 
Kakuda125 et al and suggested by Hiltunen130 et al maximum FA is a better measure 
than mean FA. Since nerves are small and can be difficult to separate from 
surrounding tissues on FA-CEI, ROI analyses are thereby sensitive to partial 
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volume effects. Nerves are often in the vicinity of muscles, which in the thigh have 
a FA range of 0.27-0.38142. Due to the potential partial volume effects in the ROI 
analysis, mean ADC was not evaluated in Study V, but has been evaluated in other 
studies. Mean ADC range reported in nerves of healthy individuals was 0.71–
1.27132, 0.71–1.56127, 0.81-1.03141 and 1.34–1.81128 (all values ×10-3 mm2/s). In a 
study on patients with carpal tunnel syndrome, the mean ADC was significantly 
altered compared to healthy individuals, except in the elderly129. In another study 
on carpal tunnel syndrome, MD was measured with considerable overlap recorded 
compared to healthy individuals130. An increase in ADC or MD could reflect 
oedema or inflammation130. ADC maps are seldom used, due to the low contrast to 
surrounding tissues127. In chronic inflammatory demyelinating 
polyradiculoneuropathy, swelling of nerve roots with increased signal intensity on 
T2-weighted or short tau inversion recovery images can be seen141. In this 
condition, mean ADC was elevated and ranged 0.84-1.70 ×10-3 mm2/s in the 
brachial and lumbar plexus, with overlap in the lower ADC range141. 
Magnetisation transfer imaging was evaluated in Study V. This is a 
technique that images the non-mobile water pool bound to macromolecules, e.g. 
myelin, which otherwise is not imaged36,37. Decreased MTR indicate a reduction of 
free water that exchanges magnetisation, which is a non-specific finding, but in 
white matter in multiple sclerosis it is related to axon damage and 
demyelination36,38. MTR is not only correlated to myelin content, but also to 
inflammation and oedema39. MTR has been used in vivo in human healthy 
nerves40,41, although no studies on peripheral nerve pathology have been published. 
In Study V only one patient had reduced MTR and no statistical significance was 
found between the groups. Although a sural nerve biopsy in one patient showed 
moderate loss of myelinated fibers, the amount of myelin loss might be too small 
for detection with MTR. 
 
 
5.2 CLINICAL IMPLICATIONS 
Study IV showed that nerve diffusion tensor imaging could detect diffusion 
alterations in OBs in PD patients as a group, albeit the intra-individual variability 
was high. 
Study V showed that nerve diffusion tensor imaging could, in SCA patients 
with PNP, detect diffusion alterations in peripheral nerves. 
 
 
5.2.1 Other published studies 
Several studies have evaluated DTI in carpal tunnel syndrome129,130,137 and a 
moderate/minor correlation of FA and ADC with ENeG was found143. Other 
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studies have investigated chronic inflammatory demyelinating 
polyradiculoneuropathy, Charcot-Marie-Tooth disease, Guillain-Barré syndrome G-
B, Churg-Strauss syndrome125,126,141, compression from neoplasms or disc 
herniations135,136, median nerve repair144, optic nerves115,145 and assessed axonal 
regeneration in animal peripheral nerves122,123,146. 
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5.3 NERVE DIFFUSION TENSOR IMAGING CONSIDERATIONS 
 
MR-scanner – B0 
Scanning at higher Tesla results in higher SNR, albeit there are more susceptibility 
artifacts14,15. A homogenous B0 within the voxel is a necessity. Since the human 
body itself will alter B0, shimming has to be performed. To reduce Nyquist 
ghosting artifacts, a reference scan and shimming are performed. The imaged body 
part of interest is best positioned as close to the center of the magnet as possible, 
where the most homogenous magnet field exists70. 
 
RF-pulse – B1 
At higher field strengths, fat suppression is more problematic due to RF 
inhomogeneities70,120. A small FOV excitation using parallel RF transmission would 
improve the spatial resolution147. Transmitter coils can have less uniform B1, 
compared to the body coil (bore)70. 
 
Coils 
It is often better to use smaller coils, since the largest noise contribution generally is 
from the patient. Array coils are used for parallel imaging. Receiver coils have to be 
positioned 900 against B0 to detect the signal. Prescan is performed to characterise 
and optimise the transmitter and receiver coils70. Calibration of the gradient coils is 
part of a quality assurance program33. 
 
Gradient strength, Slew rate 
Gradient coils with high strength, ramped sampling and slew rate will result in 
shorter TE (Eq. [5]) and higher SNR15,68,96,105. 
 
Patient motion 
Cardiac gating could be considered to reduce pulsation artifacts12. Measuring 
motion can be complicated, especially since there often is a small anatomical drift 
that can add up to a considerable distance during long examinations101. However, 
new techniques are currently developed, e.g. using a retrospective approach for 
image reconstruction or a camera for motion correction102,103. 
 
SNR-check 
Reporting the SNR in studies could be considered, since a low SNR can cause FA 
bias. In 1.5 T and 3.0 T, a SNR of 20 is recommended in ‘high-FA’ regions 
(approximately FA 0.80) and a SNR of 40 in ‘medium-FA’ regions (approximately 
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FA 0.45) regions. In ‘low-FA’ regions (approximately FA<0.20) a SNR of 50 is 
recommended at 1.5 T, and SNR of 70 at 3.0 T89. 
 
EPI sequence 
Using a twice-refocused diffusion spin echo pulse results in less eddy current 
artifacts, albeit a longer TE76. The bandwidth is narrow in the phase-encoding 
direction. Nyquist ghosting artifacts are seen in the phase-encoding direction91. 
Geometric distortion reducing techniques may be considered, e.g. b-zero field 
mapping, or acquiring and combining k-space in reverse directions33,72. 
 
Parallel imaging 
There is a trade-off in the acceleration factor. By collecting fewer lines in k-space 
SNR decreases, but it also shortens TE, which increases SNR. Using a too high 
acceleration factor produces noisy images, with noise especially seen in the image 
center17,89. An acceleration factor of 2-2.1 is recommended17,92. 
 
Phase-encoding sampling 
Faster sampling in the phase-encoding direction results in less artifacts, except for 
Nyquist ghosting75. 
 
Partial Fourier 
A partial Fourier encoding of 60% is recommended, to shorten TE17. 
 
Matrix, Slice thickness 
Matrix and slice thickness will affect SNR. Partial volume effects can be seen in 
ROI measurements of small structures. Due to averaging, anisotropic voxels will 
have quantitative measurements that depend on the nerve direction within the 
voxel33.  
 
Fat suppression 
Consider an adiabatic pulse for fat suppression at higher field strengths, since it is 
more robust to RF inhomogeneities than SPIR70,120. 
 
B-zero 
One b-zero (or low b-value) image for every 5-10 diffusion-weighted image is 
considered optimal106,107. 
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B-value 
Studies examining the median nerve have for fiber tracking found an optimal b-
value of 1025 s/mm2 at 1.5 T69 and between 1000-1400 s/mm2 at 3 T71. According 
to Eq. [4] a higher b-value will produce larger echo attenuation, thus a lower SNR68. 
Comparing studies which have used different b-values is problematic, since the 
trace, MD and FA all depend on the b-value72,73. 
 
Diffusion sensitising gradients and directions 
For good tensor orientation estimation, at least 30 diffusion-encoding directions is 
recommended15. As long as the diffusion-encoding gradient directions are well 
balanced, comparing different gradient schemes between different studies is 
feasible74. Commonly, the b-zero is collected first and thereafter the different 
diffusion-encoding directions in a series, with all NSA for every direction collected 
together. 
 
TR 
In DTI, a T2-weighted spin echo sequence14 is used with diffusion-encoding 
gradient pulses, necessitating a sufficiently long TR. Tissue T1 relaxation time 
increases with a higher magnetic field and a longer TR is needed34. 
 
NSA 
To improve SNR, extra NSA or more diffusion-encoding gradient directions can 
be used, e.g. doubling NSA or gradient directions, will have the same effect on the 
scanning time15,74. SNR α √NSA, e.g. four NSA doubles SNR96. 
 
Conversion of DICOM 
Converting DICOM to another format, e.g. NIFTI, allows non-vendor-supplied 
post-processing, e.g. software tools from the FMRIB software library 
(http://www.fmrib.ox.ac.uk/fsl), provided by FSL. 
 
Data quality check 
Check data quality at baseline, following eddy current/motion correction and the 
final data148, e.g. using ‘FSLView’ in three dimensions (FSL). A FA-value > 1 
should not be possible. If this is registered (due to negative eigenvalues, since the 
diffusion-weighted images have higher signal intensity than the b-zero image), it 
suggests too much noise or non-corrected misregistration16,148. 
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Eddy current correction/Motion correction 
The single-shot diffusion-weighted EPI sequence is relatively insensitive to patient 
motion during the collection, but motion between acquisitions has to be 
corrected15,67. Large motion can be more difficult to correct, although new 
techniques are evolving102,103. The bipolar diffusion diffusion-encoding gradients 
have a high magnitude and long duration, which result in eddy currents that need 
to be corrected72. 
 
B-matrix reorientation 
When adjusting for patient motion, B-matrix should be corrected, i.e. the rotational 
component should be extracted and applied to the encoding vectors33,72,101. 
 
Fitting the diffusion tensor 
There are several ways to estimate the diffusion tensor from the diffusion-weighted 
data and in FSL ‘ordinary linear least squares methods’ is used148. 
 
Parametric map computation 
Finally the parametric maps, e.g. MD and FA, are computed33,148. 
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5.3.1     The optimal voxel 
The voxel size chosen for analysis will theoretically depend on what type of 
pathology is of interest to investigate. However, it is optimal to use isotropic 
voxels, since quantitative measurements thereby are independent of the nerve 
direction33. If an extremely small voxel located within an axon is considered, 
diffusion is isotropic. When the voxel size is increased, several axons are included 
and diffusion becomes anisotropic25. With further increasing voxel size, additional 
tissues are included, i.e. collagen, fat, vessels et cetera. As a simple approximation, a 
1.0 mm3 voxel would contain 5100-40000 parallel axons, including other tissues. It 
would be of interest to investigate the relationship of the voxel size and diffusion 
data in peripheral nerves. Different voxel sizes might produce equal diffusion data, 
despite a difference in the contribution of other tissues. Due to the inherently low 
SNR in DTI, using the largest possible voxel that yield equal diffusion data, would 
be optimal. 
Interestingly, even microcirculation can be analysed with intravoxel 
incoherent motion imaging DWI13,149 and functional DWI has been investigated as 
well11,31. 
 
 
5.4 PARKINSON’S DISEASE – 
 SUBSTANTIA NIGRA AND CORPUS CALLOSUM 
Study IV 
FA values for SN were close to those previously published62,116. The mean λy 
was high in SN, indicating a diffusion direction of SN in an anterior-posterior 
direction, which can be noted as green in FA-CEI in a study by Vaillancourt62et al. 
In a study by Adachi150et al it was noted that in SN the nerve fibers had a similar 
direction, indicating that the subROIs were placed correctly in Study IV. Locating 
and delineating subregions within the mesencephalon is difficult with 1.5 T and 3.0 
T, although results on 7.0 T are promising151.  FA was reduced in SN in the PD 
group, in both DTI series. As in the Vaillancourt62et al study, MD was not affected, 
suggesting that FA is a more sensitive biomarker in SN. In the first DTI series, 
both FA and MD were altered in OB, which could be associated with more 
advanced synucleinopathy changes, since OB is affected earlier than SN. In PD 
patients, asymmetry in symptoms44 and 123I-Ioflupane putaminal binding is 
common152. However, in Study IV the aim was not to study asymmetry in SN 
diffusion. Since the resolution of the diffusion technique is relatively low and since 
pars compacta of SN is a small subregion of SN, it would be very difficult to 
determine asymmetries, and the mean value of both SN was used instead. In a 3.0 
T study using anatomical ROI placement significant asymmetric FA values were 
found in PD patients in the rostral SN153, although CV was not evaluated. In a 
voxel-wise based statistical study on the effect of MR-scanners on brain asymmetry, 
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changes measured over time on the same scanner were relatively stable. Upgrading 
of the scanner had a small effect on FA asymmetries, while different scanners 
significantly affected FA, even when the exact same models of scanners were 
used154. DaTSCAN is a powerful tool in PD diagnostics typically showing reduced 
123I-Ioflupane putaminal binding. However, the radiation dose to the patient must 
be considered, especially upon repeated examinations. 
Diffusion alterations in white matter in PD patients have been observed in 
the genu of the CC155, whereas in another study no alterations were found when the 
entire CC was examined63. In Study IV, diffusion was measured in the trunk of the 
CC and no alterations were observed. 
 
 
5.5 THE ‘HUDDINGE SPINOCEREBELLAR ATAXIA FAMILY’ – 
 BRAIN AND SPINAL CORD 
Study V 
Clinical phenotype, ENeG findings and MRI abnormalities of the brain, spinal 
cord and peripheral nerve of the Swedish ‘Huddinge SCA Family’ are compatible 
with a slowly progressive autosomal dominant neurodegenerative SCA disorder. 
Interestingly, this disorder is characterised by atrophy of the cerebellum, brainstem 
and spinal cord with PNP. Atrophy of the spinal cord has only been described in 
SCA3/MJD, while it is a rather common finding in Friedreich’s ataxia patients59,156. 
Friedreich’s ataxia and the most common SCAs have been ruled out in the index 
case and genotype studies are ongoing. Altogether, this disorder is likely to be a rare 
SCA type. 
Conventional MRI is insensitive to detect early brain atrophy and expertise 
is needed to grade advanced changes in the cerebellum and brainstem. High-
resolution 3D MRI volumetry with a voxel size of 1 mm3 can reliably quantify 
posterior fossa structures and is better than conventional 2D MRI157. MRI 
volumetry in SCA has shown correlation of specific atrophic regions with clinical 
symptoms158. In Study V, T1-weighted imaging with a voxel size of 1 mm3 was 
used for MRI volumetry and the brain was segmented into mesencephalon, pons, 
medulla oblongata, cerebellum and cerebrum65. Vermis was not separated from the 
cerebellar hemispheres, since there are no clear landmarks159. All patients in Study 
V had atrophy of the pons, medulla oblongata and cerebellum, which was 
statistically significant. In SCA the cerebellar dysfunction is mostly caused by 
Purkinje cell degeneration160. The clinical-pathological correlations in 
spinocerebellar ataxias depend on cerebellar anatomy and its connections to 
extracerebellar structures, rather than its cortical divisions57. In some patients of 
SCA2, SCA3/MJD, SCA7 and SCA8 the ‘hot cross bun’ sign has been noted66, 
which none of the patients in Study V had. Voxel-based morphometry has been 
used in SCA65,161,162. It is a statistical group analysis technique and the small size of 
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participants in Study V precluded this kind of analysis. Due to time-constraints 
neither DTI nor proton MR spectroscopy of the brain was performed. In SCA1 
and SCA2, proton MR spectroscopy has shown decreased concentration of N-
acetyl-aspartate in the cerebellum and pons159. N-acetyl-aspartate is regarded as a 
marker of nerve integrity157. 
MRI is a time-consuming examination and it is important for participants to 
remain motionless during the investigation. Due to time constraints only sagittal 
T2-weighted images of the spinal cord were performed, although high-resolution 
3D sequences would have been preferred. At the midlevel of each vertebra from 
C1 to Th12, the midsagittal distance of the spinal cord was measured and a mean 
value was calculated for each individual. In all patients, this mean value was less 
than for the healthy controls, which was statistically significant. Further studies are 
necessary to evaluate which specific parts of the spinal cord that are involved. In 
SCA3/MJD and SCA6 patients, the upper spinal cord has been evaluated with 
high-resolution T1-weighted MRI and the mean cross sectional area was reduced in 
SCA3/MJD, but not in SCA659. 
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6. CONCLUSIONS 
Nerve diffusion tensor imaging can in vivo visualise and analyse peripheral 
nerves, which have a characteristic diffusion pattern. Due to this pattern, other 
diffusion imaging approaches can be utilised, such as DDI or unidirectional MIP. 
In a clinical study on patients of the Swedish ‘Huddinge SCA Family’, who 
had clinical and ENeG verified peripheral neuropathy, peripheral nerve diffusion 
tensor imaging was evaluated. All examined patients had decreased maximum FA 
in a peripheral nerve, compared to healthy controls, which was statistically 
significant. 
Nerve diffusion tensor imaging can in vivo visualise and analyse OBs. Using 
a novel approach, taking advantage of the DTI technique’s inherent directional 
information, OBs were localised and analysed in a clinical PD study. In the PD 
group, compared to healthy controls, mean FA was decreased and MD increased, 
which was statistically significant. This was hypothesised, since α-synuclein 
inclusions and Lewy neurites interfering with nerve structure have been detected in 
OBs. However, the intra-individual variability was high, owing to the OB’s small 
size and location susceptible to artifacts, and the difference between the groups was 
significant only for the first of two series. A major limitation in Study IV was the 
extensive exclusion of participants due to head movements. Several new promising 
DTI techniques have been developed concerning motion correction102,103, artifact 
reduction75,97-99 and increased spatial resolution, e.g. parallel RF transmission147, a 
zonally oblique multislice technique to excite a small field of view145 or even 7.0 
T163. Using high-field conventional MRI to evaluate OBs in PD patients would be 
interesting, since 3.0 T and 9.4 T in vitro studies of normal OB can identify 
lamination in OBs8, i.e. the cellular layers. 
Reporting SNR in future clinical studies could be considered, since DTI is 
suffering from low SNR, which can lower the precision, accuracy and cause bias in 
FA. 
Pathological nerves have decreased FA, which could be used in a clinical 
setting. However, implementing nerve diffusion tensor imaging would require a 
low variance in diffusion measures. Although challenging, nerve diffusion tensor 
imaging with low variance would be valuable as a non-invasive diagnostic tool in 
PNP. 
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